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Taxonomic Classification 
Toxoplasma gondii is a worldwide prevalent, zoonotic non-flagellated apicomplexan parasite. As a 
member of the Phylum Apicomplexa, T. gondii has an apicoplast, a non-photosynthetic organelle, 
which is homologous to the chloroplast. Moreover, as a member of the Coccidia class, T. gondii is an 
obligate intracellular and cyst forming parasite that infects its hosts through the gastrointestinal tract, 
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Toxoplasma gondii (T. gondii), considered as one of the most successful parasites worldwide, was 
concurrently discovered by Nicolle and Manceaux and Splendore in 1908 (Nicolle and Manceaux, 
1908; Splendore, 1908). The parasite was isolated from two different hosts, a rodent species named 
gundi and a rabbit in which the organism was wrongly identified as Leishmania (Splendore, 1908). 
The isolated specimen took its name based on its morphology (toxo: arc-shaped, plasma: life) and on 
one of the first described hosts (gondii: gundi). However, the elucidation of the complete life cycle of 
T. gondii with felids as definitive hosts was not concluded till the late sixties and early seventies due 
to the different infectious stages and the wide range of intermediate hosts (Hutchison et al., 1969; 
Dubey et al., 1970; Sheffield and Melton, 1970). This discovery was a major breakthrough in 
medical and veterinary sciences, which led to the identification and the elucidation of the life cycle 
of different economically very important related parasites such as, Neospora caninum, Sarcocystis 
spp, etc. (Dubey, 2010). 
1.1 Infectious stages  
Toxoplasma gondii has three well-differentiated infectious stages: i) Tachyzoites, ii) Bradyzoites and 
iii) Sporozoites. The three stages are haploid and have the characteristic apicoplast, a non-
photosynthetic organelle, which is homologous to the chloroplast shared by all the members of the 
Phylum Apicomplexa. A graphical scheme of the morphology of the three infectious stages is shown 
in Figure 1.5. 
1.1.1 Tachyzoites: 
Tachyzoites are the free fast replicating form of the parasite present during the acute phase of 
infection. They have the typical arched shape that gave the name to the species, with a size of 2-4 µm 
wide and 6-8 µm long (see Figure 1.2). Although tachyzoites lack any visible motility structures they 
move through undulating, gliding and rotating movements and they are able to penetrate and 
replicate in several types of host cells (Chiappino et al., 1984; Dubey, 1998). Active penetration of 
the cells is mediated by secretion of different micronemes, rhoptries and dense granule proteins, 
which are also responsible for the formation of the parasitophorous vacuole (PV) in which the 
parasite replicates by endodyogeny, protected from the host immune system (Carruthers and Sibley, 
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Figure 1.2: Purified tachyzoites of the RH strain. Source: National Reference Center (NRC) for Congenital 
infections, Toxoplasmosis, WIV-ISP, S. De Craeye.   
1.1.2 Bradyzoites: 
Bradyzoites are the slow replicating stages of the parasite encapsulated in intracellular cysts within 
the host tissues. They share the bowed shape with the other two infectious stages of the parasite 
(tachyzoites and sporozoites) and they are 5-8.5 µm long and 1-3 µm wide (Dubey, 1998). Tissue 
cysts can contain from a few bradyzoites to thousands of them depending on the strain and/or the 
time post infection (Figure 1.3). Tissue cysts are mainly present in neural, cardiac and skeletal 
muscular tissues although they can also be found in other visceral or muscular tissues (Dubey, 2010). 
 
 
Figure 1.3: A tissue cyst and a ruptured tissue cyst with freed bradyzoites using phase contrast microscopy 
.Source: National Reference Center (NRC) for Congenital infections, Toxoplasmosis, WIV-ISP, S. De 
Craeye. 
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1.1.3 Sporozoites: 
Sporozoites are the result of the sexual replication in the definitive host; each sporozoite measures 
approximately 2 µm wide and 6-8 µm long. They are contained inside the sporulated oocyst; each 
oocyst contains 2 differentiated sporocyst and each sporocyst contains 4 sporozoites (Figure 1.4). 
The sporozoites are protected by 3 different layers: an outer electron-dense layer, an electron-lucent 
middle layer and a moderately electron-dense inner layer (Dubey,2010). The oocysts are sphere-
shaped stages with 10-12 µm of diameter (Figure 1.4). Remarkably, the oocysts are the resistant 
stage of the parasite and they remain viable in the environment for at least one year after excretion 
(Torrey and Yolken, 2013) and they can remain viable for at least 12 months in 2% sulphuric acid 
(Frenkel et al., 1975). It is generally accepted that sporulated oocysts survive well in a moist 
environment while they are quickly destroyed in dry conditions. There is not a maximum survival 




Figure 1.4: Pictures of a sporulated oocyst Tg-SweF2 using fluorescent microscopy (left) and phase contrast 
microscopy (right) Source: NCR for Toxoplasmosis, WIV-ISP, S. De Craeye. 
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1.2 Life cycle 
T. gondii has a facultative heteroxenous life cycle with members of the Felidae family as the 
definitive hosts and practically all warm-blooded animals as the intermediate hosts. An overview of 
the life cycle is shown in Figure 1.6. Two clearly differentiated phases are found in the definitive 
host, the intra-intestinal and the extra-intestinal phases, while in intermediate hosts only the extra-
intestinal phase occurs. 
 
The life cycle starts with the ingestion by the definitive host, mostly cats, of a chronically infected 
prey. Once in the stomach, the proteolytic enzymes will initiate the digestion of the cyst wall 
resulting in the release of the bradyzoites in the cranial part of the small intestine and the later 
invasion of the enterocytes from the intestinal epithelium by the freed bradyzoites. After numerous 
rounds of asexual replication, five different morphological stages designated from A-E will develop 
exclusively in the enterocytes of the final host. The described stages (schizonts type A-E) will 
multiply for generations before gametogony follows. The gamete formation will start between 3-15 
days after the ingestion of tissue cysts, probably when merozoites released from schizonts type D and 
E will initiate gametogony in the small intestine, commonly in the ileum. Macrogametes (female) 
will then be fertilized by bi-flagellated microgametes (male) resulting in the formation of a zygote, 
discharged into the lumen after the rupture of the infected cells. The zygote is protected by 5 layers 
of oocyst wall and shed into the environment by the definitive host (Hutchison et al., 1969). 
 
 
Figure 1.6: Schematic representation of the T. gondii’s life cycle adapted from Hunter and Sibley, 2012 
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In the environment, the oocysts will sporulate forming two sporocysts that will further develop into a 
total of 8 sporozoites per oocyst within 3-5 days. The sporulated oocysts can then be “picked up” by 
a “new” definitive host re-initiating the life cycle with less efficiency or by an intermediate host 
continuing the cycle. 
 
When ingested by an intermediate host, sporozoites will penetrate the enterocytes and goblet cells 
and will be carried to the lamina propria where they will transform into tachyzoites, “jump” to the 
blood stream and disseminate through the neural, visceral, and muscular tissues of the host (acute 
phase). Once in the tissues, some tachyzoites will transform into bradyzoites and encapsulate inside 
of a tissue cyst that can remain present life-long (chronic phase). Interferon gamma (IFN-Ɣ) is 
thought to be responsible for the transformation of the tachyzoites into bradyzoites and the formation 
and maintenance of the tissue cyst; however, all the factors regulating the formation of tissue cysts in 
vivo are not fully understood yet (Dubey, 2010; Hunter and Sibley, 2012; Jennes, 2017). This 
dissemination and encapsulation process (the extra-intestinal phase) occurs also in the definitive host 
in parallel to the intra-intestinal phase described previously. (Dubey, 2010). 
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1.3 Molecular epidemiology 
Toxoplasma gondii is a haploid eukaryotic organism, which possesses only one set of chromosomes 
in all its different stages except for the unsporulated oocysts. These oocysts are the result of sexual 
replication, which occurred in the gastrointestinal tract of the definitive host and they are present for 
a short period of time before the sporulation starts. With a total of 14 chromosomes, 7793 genes and 
an approximate size of 63.5 mega base pairs (Mbp), the T. gondii genome is longer than these of 
closely related parasite species such as Plasmodium falciparum or Cryptosporidium parvum (Khan et 
al., 2007). 
 
Initially, T. gondii was thought to be a highly clonal organism, showing almost no genetic diversity. 
However, in the early 90’s molecular epidemiology started to be taken into consideration and for the 
first time, different strains were grouped into three main lineages using the restriction fragment 
length polymorphism (RFLP) technique (Figure 1.7) (Howe and Sibley, 1995). Although this 
manuscript was first refused for publication due to a lack of editor interest and the simplicity of the 
classification, the manuscript was finally published in a different journal and since then has been 
cited many times settling the bases for the molecular epidemiology of T. gondii (Howe and Sibley, 
1995) .  
 
Figure 1.7: Representation of the first genotyping classification of T. gondii by Howe and Sibley, 1995 
 
In parallel to Sibley, Dardé et al. (Dardé et al., 1992) conducted comparable results in Europe using 
multilocus enzyme electrophoresis (MLE) , confirming the presence of the same structured 
population in North America and Europe. Even though these three main lineages differ in less than 
2% at a DNA sequence level (Grigg, 2001), strikingly, a difference in virulence of T. gondii strains 
depending on their genetic profile was established (Sibley, 2009; Su et al., 2002). 
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Since then, several molecular epidemiological studies using MLE, PCR-RFLP and microsatellite 
(MS) polymorphism-based techniques have shown the same highly structured population (clonal 
population) with three main clonal lineages (Type I, II and III) in Europe and North America (Howe 
and Sibley, 1995, Dardé et al., 1996, Ajzenberg et al., 2002; De Craeye, 2012). The existence of this 
structured population can easily be explained by different factors: i) T. gondii  can be transmitted 
between intermediate hosts bypassing the sexual replication and hence the sexual recombination in 
the definitive host (Howe and Sibley, 1995; Ajzenberg et al., 2004); ii) During the sexual replication, 
many macrogametes are not fertilized but they still develop into oocysts by parthenogenesis 
(Ferguson, 2002); iii) Definitive hosts infected concurrently with more than one T. gondii strain are 
extremely rare, hence recombination between different strains is handicapped (Ajzenberg et al., 
2004). 
 
Nowadays, although highly clonal, the T. gondii population has also been revealed to show genetic 
diversity (Table 11. and Figure 1.8). Some strains do not fit in any of the three main lineages and are 
therefore considered as atypical since their alleles could not be found in any of the main lineages 
(Ajzenberg et al., 2004). These atypical strains are endemic in tropical areas of South America such 
as, French Guiana and Brazil, where the life cycle passes more often through wild felids. These 
strains can also be found in Africa and China and rarely in North America and Europe (Ajzenberg et 
al., 2004).  
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Recent studies comparing the circulating strains worldwide and reconstructing the T. gondii 
phylogeography have provided a broader view of the genetic diversity of T. gondii in the world, with 
more than 13 different types (haplogroups) and have suggested a potential common origin of all the 
modern T. gondii strains located somewhere in South America (Shwab et al., 2014; Lorenzi et al., 
2016; Bertranpetit et al., 2017). As shown in Figure 1.8, the higher diversity of strains is found in 
South America while in Europe the vast majority of the strains are type II and mainly archetypal 
strains can be found (Type I, II and III) (Shwab et al., 2014). 
 
The differences in virulence and pathogenicity between the main lineages have been widely studied 
in the mouse model: 
o Type I: strains from this lineage are highly virulent in mice. Only one tachyzoite injected 
intraperitoneally (ip) is able to kill mice within 10 days (Lethal Dose (LD) 100%= 1 
tachyzoite) (De Craeye, 2012). 
o Types II and III: these strains are not considered virulent in mice, at least 1000 tachyzoites 
are needed to cause death when injected ip (LD >1000 tachyzoites) (De Craeye, 2012). 
 
Remarkably, most of the atypical strains are considered virulent in both mice and humans causing 
death in mice and severe ocular problems even in immunocompetent humans. However, these strains 
have not yet been widely studied. 
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Although T. gondii infection is normally associated with cats and their shedding of oocysts (Torrey 
and Yolken, 2013), carnivorism is also an important route of transmission for T. gondii within 
intermediate hosts, including humans. Three main routes of transmission are considered to be 
responsible for almost all the human and animal infections.  
2.1 Main routes of transmission 
2.1.1 Horizontal transmission, via oocysts 
Unsporulated oocysts are the result of the sexual replication in the intestinal tract of the definitive 
host (Felidae) and are shed in the environment where they become infectious after sporulation. 
Virtually all warm-blooded animals (intermediate hosts) can get infected when consuming oocyst-
contaminated drinking water, vegetables, soil or animal feed (Hide, 2016). Particularly, humans can 
also get infected while cleaning contaminated cat litter or while gardening (Hide, 2016), see Figure 
2.1 for an overview of this transmission route. 
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2.1.2 Horizontal transmission, via tissue cysts 
Once infected, intermediate hosts become carriers of intracellular tissue cysts life-long, actively 
collaborating to the successfully spread of the disease (Dubey, 2010). Carnivores and omnivores can 
therefore get infected by ingesting contaminated tissues from a chronically infected animal. The 
consumption of raw or undercooked meat has been widely proven to be highly effective to initiate 
infection in intermediate and definitive host (Aspinall et al., 2002; Su et al., 2003; Hide, 2016). The 
effectivity of this route is actually that high that still today the infection of animals is considered as 
the reference method for the direct detection of the parasite in tissues (Hide, 2016). Transmission by 
meat consumption was first described in humans in 1965 by Desmonts (Desmonts et al., 1965) and 
since then has been considered of pivotal importance (Figure 2.2) in humans. Meat borne 
transmission of T. gondii is estimated to be responsible for at least 30 % of the human T. gondii 
infections (Cook et al., 2000). 
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2.1.3 Vertical transmission 
Congenital transmission of T. gondii has been extensively documented in several species including, 
humans, sheep and mice (Hide, 2016). However, not all species are equally susceptible to this route 
of infection. For example, although different experimental attempts to reproduce congenital 
transmission were performed in pigs, these were not consistently successful (Basso et al., 2015). In 
humans, the first report of congenital transmission was described in 1939 (Wolf, 1939). When it 
occurs, it may be associated with severe clinical signs for the child or even cause abortion 
(Maldonado and Read, 2017). An overview of the sources of infection for humans that will lead to a 
vertical transmission are shown in Figure 2.3 
 
Figure 2.3: Graphical representation of the vertical transmission from the mother to the unborn baby 
 
Despite a high seroprevalence in humans (30-80%) (Opsteegh et al., 2016), relatively few cases of 
congenital toxoplasmosis are being reported, between 1/1000 and 1/10000 pregnancies according to 
the country (Dubey, 2010). The low rate of congenital transmission in humans can be explained by 
the fact that congenital transmission occurs in most cases only when mothers seroconvert during 
pregnancy (Frenkel, 1974; Maldonado and Read, 2017). Reactivation of chronic infections during 
pregnancy leading to congenital transmission was demonstrated in only a few individual cases 
(Ladas et al., 1999; Kodjikian et al., 2004; Valdès et al., 2011).  
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2.2 Toxoplasmosis, public health and economic impact 
Toxoplasma gondii is a zoonotic parasite of global interest. There is an increasing awareness 
worldwide of its public health and economic importance. Human toxoplasmosis costs in the US are 
estimated to be more than 3 billion US dollars a year considering only the medical costs (Hoffman et 
al., 2013). Toxoplasma gondii was classified as second of the 15 most important foodborne 
pathogens in function of economic impact by the United States Department of Agriculture (USDA) 
(Hoffman et al., 2013), see Figure 2.4. The Center for Disease Control and Prevention (CDC) 
estimates that foodborne toxoplasmosis is only surpassed by Salmonella on the annual numbers of 
human deaths caused by foodborne hazards. In Belgium, Toxoplasma is considered in the top 10 of 
the most important foodborne pathogens (higher public health impact) (Cardoen et al., 2009). 
 
 
Figure 2.4: Overview of the 15 pathogens responsible for 95% of the foodborne illnesses in US, adapted from 
USDA, 2013 
 
In addition, T. gondii infection in livestock is often associated with reproductive disorders, reduced 
daily weight gain and weak progeny, with consequently, important economic losses for producers 
(Buxton et al., 2007; Dubey and Jones, 2008; Dubey, 2010). For example, in Italy, the economic 
losses associated with lamb mortality and missed lactation in sheep are estimated to be more than 10 
million Euro per year (Masala et al., 2003). 
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Nowadays, the concept of animal health has been strengthened not only to the absence of disease, but 
also to the important relationship between health and welfare of the animals increasing the number of 
farms concerned by the wellbeing of their animals and providing them access outdoors. However, the 
increasingly more ethical and popular animal-friendly production systems (organic farms), where the 
animals are more exposed to environmental contamination and wildlife, may account for a re-
emergence of toxoplasmosis in livestock (Kijlstra et al., 2004; Hill et al., 2010; Dubey et al., 2012). 
A higher prevalence of T. gondii infections in livestock could also lead to an increase of human T 
toxoplasmosis in the near future.  
2.3 Human toxoplasmosis 
Human toxoplasmosis has been widely studied since the first decade of the 20
th
 century till today, 
describing several non-pathognomonic signs and symptoms, differing in severity (Weiss and Dubey, 
2009). These range from mild flu like symptoms often wrongly attributed to other causes, to severe 
encephalitis and even death. Human infections are predominantly asymptomatic in around 80 % of 
the cases (Robert-Gangneux and Dardé, 2012). However, as explained above, some specific 
population groups are more susceptible to develop severe toxoplasmosis and a correlation between T. 
gondii genotype and virulence has been described in the literature. Type I strains are considered to be 
very virulent in human hosts while type II and III strains are considered to have a lower virulence. 
Additionally, “atypical strains” have been found to be very virulent in humans, especially in people 
originating from areas where these genotypes are very rare (Europe, North America). 
 
Currently, the estimated seroprevalence in humans ranges between 20 and 80 % of the global 
population. The important inter-study variations can be explained by the use of different sampling 
strategies and detection methods (see Table 2.2), but mainly to geographical differences and effects 
of culinary traditions. An estimated 50-80% of the total European population has been considered to 
be seropositive for T. gondii and has thus been in contact with the parasite (Opsteegh et al., 2016). 
However, this prevalence does not reflect the current situation in Europe since old studies were 
included overestimating the actual seroprevalence in Europe. The prevalence is higher in Southern 
and Central European countries than in countries in the North, mainly reflecting differences in meat 
consuming habits. For example, Norway and Sweden have a lower estimated prevalence (<15%) 
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Nowadays, different strategies developed to better estimate the burden of disease in the field of 
public health are becoming more popular and have revealed the high importance of long time 
neglected diseases such as toxoplasmosis, which ranks among the most important. The key feature of 
these studies is the combination of mortality and morbidity into a single and easy to use metric 
(Devleesschauwer et al., 2014). For example, a pathogen-food relationship ranking in function of 
Quality-Adjusted Life Years (QALYs), which is a generic measure of disease burden used to 
economically evaluate the impact of a disease considering the medical interventions, ranks the 
combination T. gondii/pork in the top 2 above other more known pathogen-food combinations, such 
as Salmonella enterica/poultry and norovirus/complex foods (Batz et al., 2012). Another study in 
Europe, using the Disability-Adjusted Life Years (DALYs), which is a measure of the overall disease 
burden, estimated a total of 829,071 DALY’s due to foodborne toxoplasmosis (Havelaar et al., 
2015). In the Netherlands, T. gondii congenital and acquired infections, accounted for 3,570 DALY’s 
in 2011 (Mangen et al., 2014). In Belgium, the estimated disease burden of congenital toxoplasmosis 
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Table 2.2: Overview of different T. gondii seroprevalence studies in humans 
 
 
2.3.1 Congenital toxoplasmosis 
Toxoplasma gondii vertical transmission from the mother to the foetus is the most known and 
notorious consequence associated with a T. gondii infection. In Europe, approximately 2-8 women 
on 1000 seroconvert during pregnancy, with an estimated mean of transmission to the foetus of 25 % 
(EFSA report 2012; Opsteegh et al., 2016; Smit et al., 2017). During 2013, only in Belgium, it was 







Belgium 57 %  Breugelmans et al., 2005 
France 37 % Nogareda et al., 2013 
Netherlands 25 % Hof huis et al., 2011 
Germany 55 % Wilkings et al., 2016 
Spain 30 % Jaqueti et al., 1991 
Italy 22 % De Paschale et al., 2008 
Sweden 14 % Evengård et al., 2001 
Norway 11 % Jenum et al., 1998 
North 
America 
Canada 60 % Messier et al., 2009 
US 13 % Jones et al., 2014  
South 
America 
Argentina 59 % Fuente, 1997 
Brazil 92% Figueiró-Filho et al., 2005 
Colombia 46 % Rosso et al., 2008 
Asia 
China 11 % Liu et al., 2009 
India 24 % Dhumne et al., 2007 
Indonesia 70 % Terazawa et al., 2003 
Korea 4 % Ryu et al., 1996 
Oceania 
Australia 35 % Walpole et al., 1991 
New Zealand 33 % Morris and Croxson, 2004 
Africa 
Congo 60% Makuwa et al., 1992 
Egypt 27 % Azab et al., 1993 
Ethiopia 80 % Woldemichael et al., 1998 
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the mother during pregnancy (Smit et al., 2017).  
 
Transmission to the foetus has been widely studied and importantly, a positive correlation was found 
between gestational age and transmission rate to the unborn, from less than 10 % during the first 
trimester to higher than 60% during the last months of gestation (Figure 2.5) (Dubey, 2010).  
 
 
Figure 2.5: Representation of the percentage of congenital transmission and percentage of severity in function 
of the gestational age,  Adapted from Goldstein et al., 2008. 
 
On the contrary, the earlier the transmission occurs during pregnancy the higher the severity and/or 
malformations on the foetus are, leading to abortion, perinatal death or reduced quality of life in 
surviving children (Frenkel, 1974; Tenter et al., 2000; Pfaff et al., 2007). 
  
Figure 2.6: Brain calcifications visualised by a brain CT scan (left) and chorioretinitis (right) caused by 
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Congenital toxoplasmosis is typically associated with three main clinical signs or symptoms: i) 
chorioretinitis; ii) intracranial calcifications; iii) hydrocephalus (Figure 2.6) (Dubey, 2010; 
Maldonado and Read, 2017). In addition to the above mentioned signs, other health problems can 
also be observed less frequently such as, mental retardation, epilepsy, deafness, blindness, cataract, 
etc. (Yamamoto et al., 2000; Dubey, 2010). Noteworthy, in some cases the ocular pathologies can 
only appear several years after birth (Butler et al., 2013). 
2.3.2 Immuno-compromised individuals 
Toxoplasmosis in immune-compromised people is one of the most severe aspects of this zoonotic 
disease. Individuals whose immune system is depressed by the acquired immune deficiency 
syndrome (AIDS) and cancer or transplanted patients undergoing immunosuppressive treatment are 
susceptible to suffer from neurotoxoplasmosis (NT) due to a deficient T-cell immunoresponse 
(Mariuz and Luft, 1992; Luft and Remington, 1992; Luft et al., 1993; Robert-Gangneux and Dardé, 
2012).  
 
NT ranks high as a cause of death in AIDS patients due to severe encephalitis cursing with necrotic 
areas and hemorrhage in the brain tissue (Figure 2.7) (Renold et al., 1992; Israelski et al., 1993). 
Additionally, patients suffering from NT also show other pathologies such as, ocular toxoplasmosis 
(OT), pneumonitis, pericarditis, etc. (Luft et al., 1993; Robert-Gangneux and Dardé, 2012). In 
contrast to congenital toxoplasmosis, NT is mainly due to a reactivation of a chronic infection rather 
than to a primary infection (Luft et al., 1993).  
 
Transplants of infected organs can also be an important cause of neurotoxoplasmosis, especially 
when transplanting the heart since this is one of the organs with a higher parasitic load in humans 
(Kittleson and Kobashigawa, 2013). 
 
 
28 | P a g e  
 
  
Figure 2.7: MRI of the brain, showing a ring-enhanced mass with mild edema in the right front lobe (left) and 
a macroscopic picture of a toxoplasmic encephalitis (right) 
2.3.3 Immuno-competent individuals 
 
Toxoplasmosis in immunocompetent hosts is generally asymptomatic or will result in mild flu-like 
symptoms. However, in some cases, ocular toxoplasmosis (OT) may develop in otherwise healthy 
individuals (Demar et al., 2012; Ozgonul and Besirli, 2017). This manifestation of the disease is 
strain- and dose-dependent and remarkably, ocular toxoplasmosis in South American countries is 
mostly associated with infections in North-American and European immigrants by atypical strains, 
suggesting a host genetic impact on disease severity. Ocular toxoplasmosis can be recurrent with the 
reactivation or rupture of old tissue cysts (Holland, 2003). 
 
Nowadays, chronic toxoplasmosis is starting to be considered as a risk factor for developing different 
neurological and psychiatric disorders such as, schizophrenia, Parkinson or depression (Lester, 
2010). Moreover, behavioral changes have been described, not only in humans where toxoplasmosis 
has been associated with reckless driving and traffic accidents (Flegr et al., 2002), but also in rodents 
where infected animals are less afraid and even attracted to cat odor (Webster, 2007) and in primates 
which are morbidly attracted to leopard urine (Poirotte et al., 2016). 
Once immunity is acquired, immunocompetent individuals are thought to be protected against T. 
gondii infection life-long, although the immunity is not sterile; the sporadic rupture of old tissue 
cysts is considered to account for a re-stimulation of the immune system (Dubey, 2010). However, 
acquired immunity is thought to be insufficient to protect against re-infection with a different strain 
type or by atypical strains (Abdul-Fattah et al., 1992; Valdès et al., 2011). 
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2.3.4 Prevention and treatment  
Prevention is often associated with prophylaxis and vaccination; however, for toxoplasmosis no 
vaccine is currently available for humans (Buxton et al., 2007). Prevention of toxoplasmosis is 
mostly focusing on educational programs including hygienic measures and avoiding possible sources 
of infection. These programs that especially apply for pregnant women and immunosuppressed 
people (Hill and Dubey, 2002; van der Giessen et al., 2003), have been shown to be cost-saving and 
effective (Prusa et al., 2017). Within these preemptive measures the most important are: 
o Freezing meat and meat products at -20°C for at least 48 h 
o Cook the meat at 70°C for at least 1 min 
o Avoid consuming raw oysters, clams and mussels 
o Washing hands thoroughly and wearing gloves after and during gardening, respectively 
o Wash thoroughly fruits and vegetables 
o Avoid eating raw vegetables and salads 
o Drink mineral bottled water and avoid tap water 
 
Additionally, important efforts are currently done towards identifying different risk factors for T. 
gondii infections at a farm level aiming to achieve T. gondii free farms and thus meat. For example, 
the presence of rodents and cats have been consistently identified as important risk factors in pig 
farms (Opsteegh et al., 2016). 
 
The first effective treatment for toxoplasmosis was described in 1942 by Sabin and Warren using 
sulfonamides (Sabin and Warren, 1942). Later on, the curative effect of sulfonamides was enhanced 
by the use of pyrimethamine (Eyles and Coleman, 1953) and this combined therapy is still today the 
preferred treatment option for human toxoplasmosis. Both sulfonamides and pyrimethamine are only 
able to act against tachyzoites, consequently being useful only during the acute phase of infection. 
Encapsulated bradyzoites are protected against these drugs, which inhibit the dihydrofolic acid 
synthetase and the dihydrofolic acid reductase, respectively. Concerning CT the most frequently used 
treatment is spiramycin since this drug accumulates in high concentrations in the placenta without 
crossing the placental barrier. However, the efficacy of spiramycine for reducing the effects of 
congenital toxoplasmosis is still to be confirmed (Ajzenberg, 2011). 
2.4 Toxoplasma gondii infection in animals 
As already mentioned, any warm-blooded animal can be infected with T. gondii and develop 
toxoplasmosis; the versatility of T. gondii has made it one of the most prevalent zoonotic parasites 
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worldwide being even found in sea mammals (van de Velde et al., 2016). Within terrestrial animals, 
free ranging herbivores have a higher prevalence while animals with less environmental contact, eg 
poultry and pigs raised in intensive farms have a lower prevalence (Dubey, 2010). 
 
Infection with T. gondii in animals normally causes no clinical signs or mild non-specific signs such 
as, fever, anorexia, abdominal pain, etc. However, in some cases serious disease and even death may 
occur due to necrosis of the intestine and mesenteric lymph nodes. Additionally, focal areas of 
necrosis may develop in other organs such as heart, eyes, adrenals, etc. (Dubey, 2010). 
 
Additionally, as the interest for T. gondii increases, consumption of other types of animals, such as 
bivalves have been identified as a potential source of infection for man. Even though shellfish cannot 
develop toxoplasmosis (Paratenic hosts) they do accumulate oocysts from the environment. They 
may be useful as sentinel animals for investigating environmental T. gondii contamination (Palos 
Ladeiro et al., 2014). 
2.4.1 Domestic cats, the Trojan Horse  
Cats and other felids play a pivotal role in the life cycle of T. gondii since they are the definitive 
hosts and the only hosts in which the sexual phase occurs. As a result of the sexual replication, 
millions of infectious and extremely resistant oocysts are shed in the environment (water, crops, soil, 
etc.), accounting for all the T. gondii infections in herbivores and some of those in carnivores. After a 
primary infection, cats can shed between 25 and 810 million oocysts in the environment during a 
period of 1-3 weeks (Dubey, 2010). Although most cats have only one oocyst shedding episode in 
their life, re-infection of a cat by a different T. gondii strain may result in a second period of 
shedding of oocysts (Dubey, 2010). 
 
Most of the warm-blooded animals, including cats are mostly asymptomatic after T. gondii infection. 
However, as in humans, sporadically different non-pathognomonic clinical signs can be observed, 
ranging from mild clinical signs such as, fever, anorexia, abdominal pain, ocular disease, etc. to more 
severe signs such as pneumonia or even death (Dubey, 2010). A concomitant infection with the 
feline immunodeficiency virus (FIV) has been proven to be clinical and epidemiological 
inconsequential (Dorny et al., 2002).   
2.4.2 Livestock  
Livestock animals are known reservoirs of the parasite and the consumption of their meat is 
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estimated to account for at least 30% of the T. gondii infections in humans (Cook et al., 2000; 
Scallan et al., 2011). In this part of the literature study we review the most important features of T. 
gondii infection in the main livestock species. 
 
Pigs 
Pigs, similar to other omnivores, can get infected through oocysts contaminated feed and water or by 
ingestion of chronically infected animals. The seroprevalence in the pig population is dependent of 
the management system, with low prevalence in intensive, indoor and in/all out management 
production systems (Belgium intensive farms:  4 % (Jennes, 2017); France intensive farms: 3% 
(Opsteegh et al., 2016); while for management systems allowing outdoor access the seroprevalence 
increases importantly (USA free range farms: 25% (Guo et al., 2015), Belgium organic farms: 53% 
(Jennes, 2017). In Table 2.3 an overview of seroprevalences in pigs in different European countries 
is presented. 
 
T. gondii infection in pigs occurs normally asymptomatically or with very mild clinical signs such as, 
anorexia, fever, dyspnea, etc. Congenital transmission in pigs has been described with different 
consequences varying in severity, ranging from asymptomatic born piglets to abortion of the entire 
litter. (Dubey, 2010). Following infection of adult pigs the parasite can be found in almost all tissues 
(see Table 2.4). 
  





Wallonia, Belgium 65.00% Jennes, 2017 
Flanders, Belgium 1.00% Jennes, 2017 
Czech Republic 36.00 %  Bártová and Sedlák, 2011 
France 2.90 % Djokic et al., 2016 
Ireland 4.70 % Halová et al., 2013 
Italy 16.30 % Villari et al., 2009 
Portugal 9.80 % Lopes et al., 2013 
Serbia 9.20 % Klun et al., 2006 
Spain 9.70 % García-Bocanegra et al., 2010 
Switzerland 14.00 % Berger-Schoch et al., 2011 
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Table 2.4: Overview of the different tissues in which T. gondii has been detected in pigs  
Tissue Method Reference 
Heart MC-qPCR/bioassay Gisbert Algaba et al., 2017 
Brain MC-qPCR Gisbert Algaba et al., 2017 
M. Gastrocnemius MC-qPCR/bioassay Gisbert Algaba et al., 2017 
M. Longissimus Dorsi MC-qPCR/bioassay Gisbert Algaba et al., 2017 
M. Psoas Major MC-qPCR/bioassay Gisbert Algaba et al., 2017 
M. Diaphragm MC-qPCR/bioassay Gisbert Algaba et al., 2017 
M. Intercostal MC-qPCR/bioassay Gisbert Algaba et al., 2017 
Lungs MC-qPCR Gisbert Algaba et al., 2017 
Tongue MC-qPCR Juránková et al., 2013 
Liver MC-qPCR Juránková et al., 2013 
Kidney MC-qPCR Juránková et al., 2013 
 
In Europe and North America, even though the overall prevalence in pigs has dropped notably with 
the introduction of modern and efficient farm management systems and the general hygienic 
preemptive measures, pork still poses a risk for transmission of toxoplasmosis. Currently, in the 
United States, it is estimated that 41 % of the cases of foodborne human toxoplasmosis are caused by 
the consumption of pork, which is considered as the main source of infection for humans (Batz et al., 
2012). During the last years, in Europe the increasingly more popular animal friendly production 
systems (organic farms) may account for a re-emergence of pork as an important source of infection 
in humans (Kijlstra et al., 2004). 
 
In order to better comprehend the different factors playing a role in T. gondii infection in pigs, 
several studies have been performed aiming to detect the main risk factors. These studies have been 
recently summarized by Opsteegh et al. (2016). The main on-farm risk factors in pigs are: 
o Definitive host-related variables: presence of cats, high population of cats in the area, etc. 
o Feed-related variables: feed contamination, dry feeding, etc. 
o Housing-related variables: straw bedding, all in all out housing, hygienic measures, etc. 
o Cleaning and disinfection-related variables: duration and intensity of the cleaning before 
housing new animals, inadequate removal of dead animals, etc. 
o Confinement level-related variables: outdoor access, access to pasture, etc. 
o Rodent-related variables: cats used for rodent control, absence of rodent control, etc. 
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o Water-related variables: water supply contamination  
o Age-related variables: age of the animals, sows, etc. 
 
Chickens 
Free-range chickens are known to be extremely susceptible to T. gondii infection due to their feeding 
behavior (picking) (Dubey, 2010). The prevalence in free-range or backyard chickens is considered 
to be very high even reaching 100% in some studies. On the other hand, animals raised in intensive 
farms have a very low prevalence (Dubey, 2010). Clinical signs in chickens are rare, however, some 
of the infected animals can develop clinical signs such as, peripheral neuritis, torticollis, etc… 
Backyard and free-range chickens are thought to play a role serving as prey and a source of infection 
for wild felids helping to the spread of the parasite (definitive hosts).  
 
Cattle  
In cattle, the correlation between the actual presence of the parasite (tissue cysts) in sero-positive 
animals is still under major debate (Belluco et al., 2016). Seroprevalence in cattle is considered to be 
highly variable with values ranging from 1.9 % to 54.5% (Opsteegh et al., 2011). However, direct 
detection and also isolation of strains with bioassay are successful in very limited cases. The lack of 
correlation between seroprevalence data and parasite detection in tissues can be explained by the low 
sensitivity and specificity of most of the available indirect detection methods in cattle (Opsteegh et 
al., 2016). 
 
Infected animals normally show no clinical signs and although T. gondii has been isolated at least 
twice from aborted bovine fetuses, whether these cows aborted due to toxoplasmosis could not be 
determined because no histological examination of the fetuses was made (Dubey, 2010). 
 
In contrast to other species, T. gondii prevalence by direct detection of the parasite does not increase 
with age; indeed, calves show higher incidence of infection in tissues than older animals. Also, tissue 
cysts are not thought to persist long in most of the cattle tissues (Opsteegh et al., 2016). Within the 
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Sheep and goats 
Toxoplasma gondii has been identified as one of the main sources of infective abortion in sheep and 
goats. The actual incidence is difficult to estimate since the disease is usually sporadic (abortion 
storms) and in only few cases diagnosis is confirmed by examination of the aborted fetuses (Dubey, 
2010). Seroprevalence in small ruminants is age-related, reaching 95% in animals older than 6 years 
(Dubey, 2010). Although endogenous transplacental transmission occurs in persistently infected 
ewes and does, the majority of infections are due to environmental contamination of water and grass 
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The detection of Toxoplasma gondii infection can be achieved by either direct or indirect methods. 
The first efficient diagnostic tool was developed in 1948 by Sabin and Feldman (Sabin and Feldman, 
1948) and consisted of an indirect serological test. Since then, many different indirect methods have 
been developed for detecting anti-Toxoplasma antibodies in serum samples including, ELISA, MAT, 
IFA, etc. However, none of those tests has been able to substitute the Sabin Feldman test, which 
remains the gold standard method for serological detection of T. gondii since it is the most sensitive 
and specific method to detect T. gondii infection.  
 
Direct detection of the parasite was first performed by cat and mouse bioassays and histology. With 
the elucidation of the chemical DNA structure (Watson and Crick, 1953) a new generation of 
molecular detection methods was developed, such as polymerase chain reaction (PCR) of the B1 
gene (Burg et al., 1989) and real time PCR (qPCR) of the 529 repeated element (Homan et al., 2000), 
among many others. However, still today mouse bioassay is considered the reference method for the 
direct detection of the parasite since it is the most sensitive method able to demonstrate the presence 
and the viability of the parasite.  
 
While serology is the method of choice for screening purposes, a positive serological result only 
demonstrates that a contact with the parasite has occurred and not the actual presence of the parasite 
in the tissues. Therefore, the combination of both indirect and direct methods is considered the most 
specific and sensitive approach (Opsteegh et al., 2016). 
 
Here we summarize the most common indirect and direct detection methods for the diagnosis of 
Toxoplasma infection.  
3.1 Indirect Methods 
Serological tests, although fast and easy to perform in living animals, do not demonstrate the actual 
presence of the parasite in the tissues. However, they do account for pivotal information on the phase 
of infection, being able to discriminate between the acute and the chronic phase. This discrimination 
is possible due to the detection of different antibody isotypes (Ab).  
Three immunoglobulin isotypes play a role in the humoral immune response against the parasite 
(Figure 3.1): 
o IgM appears already 4-6 days after a primary infection and for a short period of time and not 
or almost not after a second infection 
o IgG appears between the first and second week after infection, reaches a plateau after 2-3 
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months and mostly remains present lifelong at residual levels . 
o IgA also appears during the first week after infection, disappears after 6-7 months of 
infection and reappears with every re-infection. 
 
Figure 3.1: Overview of the different antibodies expressed in function of time after infection (Robert-
Gangneux and Dardé, 2012) 
 
Therefore, the presence of IgM indicates a relatively recent primary infection, which when testing 
pregnant women may indicate a seroconversion during pregnancy and thus a risk for transplacental 
infection of the fetus (Dubey, 2010). Additionally, due to the specific 3-dimensional characteristics 
of IgM these immunoglobulins are not able to cross the placental barrier.  Therefore, the presence of 
IgM Abs in the newborn indicates actual infection of the baby and not passively acquired maternal 
Abs. 
 
Based on the different patterns of expression of antibodies the following tests are the most frequently 
used for serological toxoplasmosis diagnosis. 
Sabin Feldman Test 
The Sabin Feldman Test or Dye Test is still today considered the gold standard serological method 
for the diagnosis of T. gondii infection. It is a straightforward method which consists of the 
incubation of a mixture of live tachyzoites and complement of a T. gondii seronegative person with a 
serial dilution of the patient’s inactivated serum sample in a methylene blue dye rich medium. 
Tachyzoites incubated with serum containing anti-Toxoplasma antibodies will lose the capacity of 
taking the dye as a result of an antibody-complement-mediated lysis reaction while tachyzoites 
incubated with a negative serum will appear blue under the microscope. This test is able to detect the 
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presence of different antibodies, IgG, IgA and IgM with high sensitivity and specificity. The main 
disadvantage of the Dye Test is the requirement of live parasites (tachyzoites obtained from mice 
infected with the T. gondii RH strain).  
Agglutination and Modified Agglutination Tests (MAT) 
The agglutination assays are easy to use serological methods that are commercially available, which 
do not require special equipment. Briefly, serial serum dilutions are incubated overnight with 
formalized tachyzoites. Tachyzoites incubated with a positive serum will precipitate to the bottom of 
the well of a microtiter plate in the shape of a carpet, while tachyzoites incubated with negative 
serum will form a dot on the bottom of the well (Figure 3.2).  
 
In order to increase the specificity of the agglutination assays the serum samples can be incubated 
with mercaptoethanol prior to incubation with the tachyzoites, aiming at denaturizing the less 
specific IgM, allowing the detection of the highly specific IgG (Dubey, 2010).  
 
 
                         Kit Negative Control  
  Kit Positive Control  
 Buffer Control (Negative) 
 Serum Control (positive) 
 Negative Sample 
 Negative Sample 
 Positive Sample 
Figure 3.2: Example of the results obtained with MAT on different serum samples 
 
Indirect Enzyme-linked Immunosorbent Assay (ELISA) 
The indirect ELISA is a two-step ELISA in which the target antigen(s), coated on a solid surface, 
bind(s) serum antibodies (Ab). In a next step, the bound antibodies are detected by secondary 
isotype- and species-specific antibodies labelled with an enzyme. The enzyme will convert a 
colorless substrate-chromogene complex into a colored reaction product by an oxidation reaction. 
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The absorbance, measured by a spectrophotometer and expressed as the optical density, is used to 
determine the relative concentration of the antibodies in the samples, as compared to the known 
standards or control samples. An overview is shown in Figure 3.3. 
 
 
Figure 3.3: Overview of an indirect ELISA, adapted from Leicon technologies 
 
Nowadays, ELISA has become one of the most used techniques for indirect detection of T. gondii 
infections due to the big variety of ready and easy to use kits developed to detect different Abs in 
many different species, including humans. These are designed either to detect Abs against one single 
specific native or recombinant antigen (SAG1, GRA7, etc.) or against a mixture of antigens such as, 
total lysate antigen (TLA) containing almost all the antigens expressed by the parasite. A test using 
one specific antigen will be more specific but less sensitive since during the infection antibodies will 
not be developed equally well against different antigens (Basso et al., 2013) and a combination of 
antigens will render the technique more sensitive but less specific, since there is a higher risk of cross 
reaction with antibodies developed against other microorganisms giving false positive signals. 
 Indirect Immunofluorescence Assay (IFA) 
In IFA, whole tachyzoites are coated on a glass slide and recognized by the primary serum 
antibodies. Binding of the serum antibodies is visualized by incubation with secondary isotype- and 
species-specific antibodies labelled with a fluorescent dye, often fluorescein isothiocyanate (FITC). 
To decrease background a counterstain with Evans Blue is performed. The fluorescence microscopic 
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positive samples appear green while negative samples will appear red (Figure 3.4). Once more, 
depending on the conjugates used, different Ab isotypes can be detected. 
 
 
Figure 3.4: Results obtained with a negative serum (left) and a positive serum (right) in IFA. Source: NCR for 
Toxoplasmosis, WIV-ISP, S. De Craeye 
 
3.2 Direct Methods 
The direct detection of the parasite is achieved by using several techniques able to directly identify 
one of the stages, the parasite’s DNA or the infectivity of the parasite. 
Bioassay 
The infection of animals is still today considered the gold standard for the direct detection of viable 
parasites. Positive and negative samples are discriminated by the ability of the sample to produce 
toxoplasmosis in different animals. The most relevant experimental animal species for the detection 
of T. gondii are the mouse and the cat. Cat bioassay is performed by orally feeding cats with 
suspected tissue samples. This method is able to demonstrate the presence of infectious parasites in 
large amounts of tissues; in addition, oocysts that are shed by cats following infection can be further 
used for genotyping of the strain. However, the cat bioassay is ethically questionable, time 
consuming and expensive. Mouse bioassay is less sensitive than cat bioassay since a smaller amount 
of sample can be analyzed; however, its sensitivity is still high. The method is less costly than cat 
bioassay, but also ethically questionable. Nowadays, only a few labs perform bioassays for the 
diagnosis of toxoplasmosis. 
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Cell Culture 
As an alternative to the use of experimental animals an in vitro technique was developed using 
different cell lines as a growing media (Foulon et al., 1999; Jokelainen, et al., 2012). However, the 
sensitivity of this technique is lower than that of the bioassays and even of molecular detection 
methods. Consequently, cell culture is mainly used to maintain strains or multiply strains for antigen 
preparation. 
Microscopy 
Direct observation of all the stages of the parasite is microscopically possible: 
 
o Oocysts: T. gondii oocysts can be observed after their isolation using sucrose flotation 
techniques in fecal samples. However, morphological distinction from closely related species 
such as, Hammondia hammondi is not possible and molecular methods are needed to exclude 
false positives. 
o Tachyzoites: This form of the parasite is visible without any specific staining, but they are 
mostly present only during a short period of time in patient samples (acute phase of infection) 
o Tissue cysts: The presence of the parasite in different tissues can be shown by histological 
sections without any specific staining; however, specific staining conjugates are necessary to 
differentiate T. gondii tissue cysts from other close related parasite species.  
 
The sensitivity of these techniques is also limited, as a low parasite density in blood, tissues or fecal 
samples, etc. will result in false negative results.  
Molecular Methods: 
Molecular methods are very sensitive techniques able to detect the parasitic DNA in any type of 
matrix including all animal and human tissues, soil, vegetables or water. The sensitivity of one of 
these methods (MC-qPCR) has been recently proven to be even higher than the mouse bioassay. 
However, the main drawback of all these techniques is the inability to differentiate between dead and 
thus non- infectious parasites and viable parasites (Opsteegh et al., 2016). 
Polymerase Chain Reaction (PCR)-based methods  
The appearance and development of several PCR-based methods represented a major breakthrough 
in scientific history mostly in the field of medical and veterinary diagnosis. These methods allow to 
amplify concrete specific DNA sequences in order to proof the presence of pathogens in very low 
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concentrations. 
PCR and Real time PCR (qPCR) 
The PCR is an easy to use technique, which combines the use of thermostable polymerase enzymes 
and sequence specific primers for one or more targets. For T. gondii, many different target sequences 
have been widely used from which the most common are the B1 gene and the 529 bp repeated 
element (Burg et al., 1989; Homan et al., 2000). Although very sensitive and fast, the major 
disadvantage of this technique is the DNA extraction, which can only be performed in small samples 
up to 200 mg, resulting in a high number of false negatives and the inability of accurate 
quantification. As an alternative to classic PCR, real time PCR also called quantitative PCR (qPCR) 
was developed enabling a precise quantification, but still an insufficient amount of sample can be 
analyzed. These two techniques have been proven to be very valuable for the diagnosis of human 
toxoplasmosis, with direct detection of the parasite in different tissues or fluids such as, the placenta 
amniotic fluid, cord blood, aqueous humor, etc., but insufficiently sensitive to detect the presence of 
the parasite in the different animal tissues. (Petersen, 2007; Dubey, 2010).  
Magnetic Capture- Real Time PCR (MC-qPCR) 
To overcome the sensitivity problem, magnetic capture real time PCR (MC-qPCR) was developed 
combining the use of specific, biotin labelled probes with the capture of those probes with 
streptavidin-coated paramagnetic beads. The development of the Magnetic Capture (MC-qPCR) 
allowed the possibility of reliable parasite quantification in contrast with the qualitative results 
obtained with bioassays and classic PCR, enabling the study of the quantitative distribution of the 
parasite through the carcasses of different species (Opsteegh et al., 2010; Juránková et al., 2014; 
Aroussi et al., 2015; Hosein et al., 2016). Furthermore, the method has been recently improved 
(Chapter IV). 
 
Loop-mediated isothermal amplification (LAMP) 
As an alternative to PCR and to avoid the use of expensive thermocyclers, LAMP technology was 
developed. The sensitivity of this technique is comparable to the PCR-based methods but LAMP 
does not easily allow multiplexing. In addition, the sample size and viability of the parasite continue 
to be a major drawback (Opsteegh et al., 2016). 
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Situation of the problem and objectives 
Nowadays, it is estimated that at least 50% of the European population is Toxoplasma gondii 
seropositive (50%-80%). From these seropositive persons, it is estimated that 1 out of 3 infections is 
meat borne, identifying the consumption of raw or undercooked meat as one of the main routes of 
infection for humans. Recent studies ranking disease burden of 14 foodborne pathogens to various 
food sources, have classified T. gondii and pork in the top 2 above other better-known pathogen-food 
combinations such as, S. enterica and poultry or norovirus and complex foods. Moreover, in the US, 
41% of the foodborne toxoplasmosis cases are considered to be caused by consumption of pork. 
However, little is known about the parasite burden present in pigs intended for human consumption 
in Belgium.  
 
The general objective of this study was to study the role of pork and other meat products as a source 
of T. gondii infection in humans 
 
The specific aims of the present PhD thesis were 
 To optimize the parasite detection in host tissues (Chapter IV). 
 To study the infection kinetics in experimentally infected pigs (Chapter V): 
o  Effect of different infectious stages and strains on the parasitic load present in the 
carcass at slaughter age. 
o Effect of different strains in the presence of the parasite during the acute phase of 
infection. 
o Anatomical distribution of the parasite in pig carcas 
 To study the molecular epidemiology of T. gondii in Belgium (Chapter VI): 
o Isolation and genotyping of strains in naturally infected pigs. 























































































Optimization of the parasite’s detection in the host tissues 
 
 
Adapted from the publication: A more sensitive, efficient and ISO 17025 validated MC-qPCR 
method for the detection of archetypal T. gondii strains in meat 
 
 Gisbert Algaba I., Geerts M., Jennes M., Coucke W., Opsteegh M., Cox E., Dorny
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Abstract 
Toxoplasma gondii is a worldwide prevalent, zoonotic parasite of major importance for public 
health. Various indirect and direct methods can be used for the diagnosis of toxoplasmosis. Whereas 
serological tests are useful to prove a contact with the parasite has occurred, the actual presence of 
the parasite in the tissues of a seropositive animal is not demonstrated. For this, bioassay is still today 
the reference method. As an alternative, various PCR methods have been developed, but because of 
the limited amount of sample that can be tested combined with a low tissue cyst density, they have 
been proven to be insufficiently sensitive. A major improvement of the sensitivity was achieved with 
a Magnetic Capture based DNA extraction: by combining the hybridization of specific, biotinylated 
probes with the capture of those probes with streptavidin coated paramagnetic beads, T. gondii DNA 
can selectively be “fished out” from a large volume of meat lysate. Still, several studies showed an 
insufficient sensitivity compared to the mouse bio-assay. Here we present how we made the method 
more sensitive (99% LOD of 65.4 tachyzoites per 100 g of meat), economic and reliable (ISO 17025 
validated) by adding a non-competitive PCR inhibition control (co-capture of cellular r18S) and by 
making the release of the target DNA from the streptavidin coated paramagnetic beads UV 
dependent. The presented results demonstrate the potential of the modified MC-qPCR as a full 
alternative for the mouse bioassay for the screening of various types of tissues and meat, with the 
additional advantage of being quantitative.  
 
4.1. Introduction 
Toxoplasma gondii is an obligate intracellular and cyst forming protozoon parasite with a complex 
life cycle. Most warm-blooded animals are intermediate hosts, while only the members of the Felidae 
are definitive hosts (Tenter et al., 2000). The parasite has three infectious stages: tachyzoites, the 
free, fast replicating form of the parasite present during the acute phase; bradyzoites, the slow 
replicating form present in tissue cysts during the chronic phase of the infection and sporozoites, 
which are the result of the sexual replication in the definitive host and are present in sporulated 
oocysts (Dubey et al., 1998). 
 
Humans can get infected with T. gondii through different routes: by the consumption of raw or 
undercooked meat from chronically infected animals, by ingesting sporulated oocysts present in 
water, soil or on vegetables and by vertical transmission through the placenta (Hide, 2016). In 
humans, the majority of infections are asymptomatic while on rare occasions mild flu-like symptoms 
are observed (Ho-Yen, 2001). However, an infection of the mother during pregnancy can result in 
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congenital transmission, which may lead to foetal abnormalities, abortion and reduced quality of life 
in surviving children (Frenkel, 1974; Maldonado, 2017). Additionally, toxoplasmosis can result in 
severe disease in immunocompromised people and eye disease in otherwise healthy individuals 
(Demar, 2012; Ozgonul and Besirli, 2017). In rare cases, mostly in South America, toxoplasmosis is 
associated with severe disease even in immunocompetent people due to an infection with atypical 
strains (Pomares, 2011; Sobanski, 2013).  
 
Being zoonotic and worldwide prevalent, there is an increasing awareness of public health 
importance of T. gondii infections. For example, an estimated 50-80% of the European population is 
seropositive for T. gondii and has thus been in contact with this parasite (Opsteegh et al., 2016). In a 
recent report of the USDA ranking the 20 most important foodborne pathogens, T. gondii was 
classified as second considering the annual number of infections and the associated economic and 
medical costs (with an estimated yearly cost of more than 3.3 billion US dollars) (Hoffman et al., 
2013). 
 
Although T. gondii infection is often associated with cats and their shedding of oocysts (Torrey and 
Yolken, 2013), meat is probably the most important source of infection in developed countries. It has 
been estimated that 50% of the cases are foodborne (Scallan et al., 2011). A ranking of the disease 
burden of 14 foodborne pathogens in relation to various food sources estimated that 41 % of the 
cases of foodborne human toxoplasmosis in the United States are caused by the consumption of pork, 
which can thus be considered as a main source of infection for humans (Batz et al., 2012). Moreover, 
a pathogen-food relationship ranking in function of QALYs and costs of illness situates the 
combination T. gondii/pork on the top 2 above other pathogen-food combinations as Salmonella 
enterica/poultry and norovirus/complex foods (Batz et al., 2012). Furthermore, the increasingly more 
popular animal friendly production systems (organic farms) and the fact that one pig may be 
consumed by an estimated 200 to 400 individuals may account for a re-emergence of pork as a main 
source of infection (Fehlhaber, 2003; Kijlstra et al., 2004). 
 
Several indirect and direct methods have been developed for the detection of T. gondii. While 
serology is the method of choice for screening purposes, a positive result only demonstrates that a 
contact with the parasite has occurred and not the actual presence of the parasite in the tissues. The 
direct detection of the parasite on the other hand is often laborious, costly and insufficiently 
sensitive. While bio-assay is, together with cell culture (Jokelainen, 2012), still the only test capable 
of demonstrating the presence of infectious parasites, it is time consuming, expensive and implies the 
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use of laboratory animals. Histological and molecular methods have been proven to be insufficiently 
sensitive for demonstrating the parasite in meat samples because of a non-homogeneous and low 
tissue cyst density in meat. This, together with the small amounts of sample that can be tested with 
commercially available kits (up to 50mg with commercially available DNA extraction kits) often 
result in high numbers of false negatives (da Silva and Langoni, 2001; Hill et al., 2006). Also, 
although detection of parasites in tissue samples is significantly higher in seropositive pigs, the 
parasite has been isolated from seronegative animals. This accentuates the need of combining both, 
indirect and direct methods in order to estimate the role of meat as a source of infection for humans 
(Opsteegh et al., 2016).  
 
Opsteegh et al. developed a Magnetic Capture qPCR (MC-PCR) that enables analysis of tissue 
samples of up to 100g (Opsteegh et al., 2010). This method combines a specific DNA extraction and 
concentrating method (based on the hybridization of specific, biotin labelled probes to a T. gondii 
target sequence with a capture with streptavidin coated paramagnetic beads) with a sensitive and 
specific qPCR. However, a recent study showed certain disagreements between the MC-qPCR and 
mouse bio-assay in pig samples (Opsteegh et al., 2016). 
 
We aimed to improve the MC-PCR method to make it even more sensitive, more economic and 
suitable for ISO validation so that it can be routinely used in a diagnostic lab. We achieved this by 
adding the co-capture of cellular r18S as a means of keeping track of the extraction and as a non-
competitive PCR inhibition control, by making the release of the target DNA UV dependent and 
more efficient, by reducing incubation times and by reducing the cost through a comparison of 
reagents. Moreover, once optimized, the new method was subjected to an ISO 17025 validation to 
objectively confirm its robustness and reliability. We have chosen pork as the main matrix for the 
validation process due to its perceived importance in the transmission of T. gondii to humans. 
4.2. Materials and Methods 
4.2.1 Toxoplasma gondii strains 
In order to study the main T. gondii lineages, different strains were used: T. gondii RH strain (Type I, 
high virulence in mice), T. gondii IPB-LR (type II, low virulence in mice) and T. gondii IPB-G 
(Type II/I, a hybrid rare strain virulent in mice). The strains were genotyped by the CBR (Limoges, 
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4.2.1.1 Preparation of a Quantified Tachyzoite Suspension for Spiking Experiments 
A purified T. gondii RH strain tachyzoite suspension was quantified using a Bürker counting 
chamber and a phase contrast microscope (amplification 400X) (Nikon Eclipse Ni, Nikon, Brussels, 
Belgium) and diluted accordingly to obtain a final concentration of 10
7
 tachyzoites per ml in PBS 
supplemented with 0.01% bovine foetal calf serum (BFCS). Starting from this stock suspension, the 








, 500, 250, 125, 10
2
, 50, 25 and 10 
tachyzoites per ml and stored at -20°C till further use. 
 
4.2.1.2 Preparation of Tissue Cysts  
Seventy-five Swiss white outbred mice (Janvier Labs, Rennes, France) were intraperitoneally 
inoculated with the T. gondii IPB-LR (type II) or IPB-G (Type II and I) strains. The mice were 
observed daily and a humane-endpoint was defined to limit the suffering of the mice in case of 
disease (Ethics committee licence n: 20140704-02). After 6 weeks post infection, the mice were 
euthanized by decapitation and their brains were collected and homogenized in the presence of PBS 
supplemented with penicillin and streptomycin using a potter homogenator. The concentration of 
tissue cysts was determined by counting three times a volume of 8 µl with a phase-contrast 
microscope (Nikon Eclipse Ni, Nikon, Brussels, Belgium).  
 
4.2.1.3 Isolation and Purification of T. gondii Tissue Cysts for Use in Spiking Experiments 
Toxoplasma gondii tissue cysts were separated from the brain homogenate by centrifugation on a 
Percoll gradient. The protocol was kindly provided by the French Biological Resource Centre (BRC) 
Toxoplasma, and was based on the publication of Blewett et al. (1983). Briefly, the homogenized 
brains were transferred to a 30 ml conical glass centrifuge tube and two different concentrations of 
Percoll (Ge Healthcare, Diegem, Belgium) were carefully applied on the bottom of the glass tube 
(first, a 30% Percoll solution and then a 90% Percoll solution). After centrifugation at 1750 g for 15 
min at room temperature (RT), the brain cysts were concentrated in the 30% Percoll layer. This layer 
was then collected and the Percoll was washed away by dilution in PBS, followed by centrifugation 
at 1750 g. The obtained brain cysts pellet was then resuspended in a few ml of PBS and was then 
transferred to a small Petri dish and observed with a phase contrast microscope (Nikon Eclipse Ni, 
Nikon, Brussels, Belgium). The required amount of brain cysts for each spike were then fished out 
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4.2.2 Capture Probe design and UV mediated elution  
We aimed to match the efficiency of the magnetic capture described by (Opsteegh et al., 2010) with 
the sensitive ISO 15189 validated qPCR already in use in the laboratory. This qPCR method has 
been published before and amplifies an amplicon of 106bp inside the 529bp repeated element 
(GenBank ascension number: AF146527) (De Craeye et al., 2011). For this, the reverse capture 
probe (ToxCap RB) had to be redesigned further away on the target sequence. The sequence of the 
new capture probe was evaluated for secondary structures, melting temperature and dimer formations 
using several bioinformatics analyses: To predict secondary folding structures and hybridization of 
linear ssDNA the Mfold web server (online: http://unafold.rna.albany.edu) was utilized. Further 
basic oligo analysis was performed using the OligoAnalyzer 3.1 on the Integrated DNA 
Technologies website (IDT, online: http://eu.idtdna.com/calc/analyzer). To confirm the results 
obtained with the bioinformatics analysis different experiments were performed (data not shown).  
 
As an ISO 17025 validation was aimed for the implementation of the modified MC- qPCR for 
diagnostic purposes, a non-competitive internal amplification control (NCIAC) had to be designed to 
make the whole course of the process traceable, starting from the lysis step till the qPCR result. The 
cellular r18S gene was chosen for this purpose as it was already implemented in the ISO 15189 
validated and previously published qPCR (De Craeye et al., 2011). Here, both primers and the dual 
labelled probe were selected on a very conserved region of the r18S gene and are able to amplify and 
detect an amplicon of 138bp within the DNA of all livestock species and was also tested successfully 
on human DNA and other animal species. To further extend this “universality”, two new capture 
probes (r18SCapFw and r18SCapRV) were designed further away of the primers VF1 and VR1. 
Using the r18S co-capture as an NCIAC enables not only to exclude false negative results due to 
PCR inhibition; a suboptimal qPCR result will also show something went wrong during the 
extraction and DNA capture process.  
 
Whereas the very high binding affinity of the streptavidin-biotin interaction is especially suitable for 
the magnetic capture method, it also hampers the subsequent release of the captured DNA. The 
necessity to break the streptavidin-biotin to elute the DNA was avoided by designing the capture 
probes with a UV cleavable spacer between the biotin and the oligo molecules (5' PC Biotin). 
An overview of all the used oligos is given in Table 4.1. All the oligo’s were synthetized by 
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Table 4.1: Overview of the used oligonucleotides and their modifications.  































CGCCCTCTTCTCCACTCTTCAATTCTCTCC - 3' 








82.9 This study 
ToxCap URB 
5’-PCBio/CUCCUCCUCCCUUCGUCCAAGCCUCCGACUCUGUCUC 
CCUCGCCCUCUUCUCCACUCUUCAAUUCUCUCC - 3' 
























T2 5’-CGGAGAGGGAGAAGATGTT- 3' 60.1 De Craeye, 2011 
T3 5’-GCCATCACCACGAGGAAA- 3' 59.9 De Craeye, 2011 






VF1 5’-GATTAAGTCCCTGCCCTTT- 3' 58.0 De Craeye, 2011 
VR1 5’-GATAGTCAAGTTCGACCGTCTT- 3' 60.8 De Craeye, 2011 
VP 5’-TexRed/CACACCGCCCGTCGCTACTACC/3IAbRQSp- 3' 70.1 De Craeye, 2011 
Tm: melting temperature; Ref: reference; T-CP: thymine captures; U-CP: uracil modified captures; NCIAC: not competitive inhibition 
amplification control. Modifications:  The capture probes were modified with a photo cleavable biotin (PCBio) at the 5’end. The 
detection probes have the following reporter/quencher combinations: FAM/ZEN+3IABkFQ to detect Toxoplasma gondii and 
TexRed/3IAbRQSp for the NCIAC. 
 
4.2.3 MC-qPCR  
Prior to the optimization of the modified MC-qPCR method a wide-ranging market study was 
performed in order to choose the best quality-prize reagents and different concentrations of the MC-
qPCR reagents were tested. Moreover, different temperatures and incubation times were assessed for 
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4.2.3.1 Sample Preparation 
4.2.3.1.1 Homogenization and Lysis 
A meat sample was cleaned by removing fats and connective tissues and was then cut into small 
pieces of approximately 1 cm
3 
using sterile knives and tweezers. Hundred grams of the cut meat were 
then transferred to a filtered pedal homogenator bag (Bagpage XR, Interscience, Paris, France) with 
2.5 ml of lysis buffer (100 mM Tris HCL, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 40mg/l 
proteinase k (30 mAnson-U/mg; Amresco, Ohio, USA), pH = 8.0 ± 0.2) per gram of tissue (250ml) 
as described by (Opsteegh et al., 2010).  
 
The cut meat sample and the lysis buffer contained inside the bag was homogenized in a pedal 
homogenator (Labconsult, Brussels, Belgium) for 2 min at maximum speed and incubated at 55°C 
overnight. The following day, the sample was homogenized for one additional minute with the pedal 
homogenator and incubated 45 more minutes or until the foam disappeared. The lysate was then 
recovered through the filter of the bag and transferred to a 500 ml centrifuge bottle and centrifuged at 
3500 g at 20 °C for 45 min to remove remaining cell debris. Fifty millilitres of the cleared lysate was 
then transferred to a 50ml polypropylene tube for further use and as a backup.  
 
4.2.3.1.2 Removal of the Free Biotin 
To avoid interference of naturally present free biotin in the meat lysate, it was removed using 
streptavidin coated agarose beads. Briefly, 12 ml of the cleared meat lysate was transferred to a 15 
ml polypropylene centrifuge tube and incubated at 100°C for 10 min to inactivate the proteinase K. 
After inactivation, the extract was cooled down to room temperature and centrifuged at 3900 g to 
settle the eventual formed flocculation. The supernatant was then transferred to a new 15 ml tube. 
Meanwhile, 50 µl of streptavidin agarose beads (binding capacity >330 nmol/ml; solulink, San 
Diego, USA) were washed three times in PBS. The washed beads were then added to the lysate and 
the whole was incubated for 45 min at room temperature under gentle rotation. The beads were then 
removed by a centrifugation step at 3500 g for 15 min and 10ml of the biotin-free supernatant was 
transferred to a new 15 ml centrifuge tube for DNA extraction (magnetic capture). 
 
4.2.3.2 Magnetic Capture of the Target DNA 
4.2.3.2.1 Hybridization with the Biotinylated Capture Probes  
The specific biotinylated capture probes were added to 10ml of the cleared biotin free lysate to 
capture cellular r18S and T. gondii (AF146527) DNA at a final concentration of 20 attomols and 1 
picomol per ml, respectively. See Table 4.1 for an overview of the used capture probes. 
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Subsequently, the sample was first incubated at 95°C for 15 min followed by incubation at RT for 15 
min in order to hybridize the probes with the complementary target DNA sequences. 
 
4.2.3.2.2 DNA Capture Using Streptavidin Coated Paramagnetic Beads 
During the hybridization step, the streptavidin coated paramagnetic beads with a binding affinity > 
2.5 nmol/mg (Solulink, San Diego, USA) were prepared as follows: 200µg of beads (or 20 µg/ml of 
biotin-free lysate) were transferred to a 1.5ml microtube and washed by adding 1ml of binding and 
washing buffer (B&W buffer, 50 mM Tris HCl, 150 mM NaCl, 0.005 % tween 20, pH 8.0 ± 0.2). 
After mixing, the buffer was removed by placing the tube in a magnetic rack (Magnarack, 
Invitrogen, Massachusetts, USA) to retain the beads against the magnet. The supernatant was 
removed and this washing step was repeated twice. Finally, the beads were resuspended in 100µl of 
B&W. 
 
Once the hybridization step finished, the 200 µg of washed paramagnetic beads were added to each 
sample and the whole was incubated at room temperature while rotating for 60 min in order to 
capture the biotinylated probes hybridized with the target DNA. The tubes were then placed on a 
magnetic rack (Dynamag 15, life technologies, Massachusetts, USA) until the streptavidin coated 
paramagnetic beads were collected along the tube wall. The supernatant was then discarded and the 
beads were resuspended in 1ml of B&W buffer and carefully transferred to a 2ml microtube. The 
beads were then washed with 1ml of B&W buffer to remove the remaining lysate. Finally, the beads 
were resuspended in 100µl of TE buffer pH 8.0 (Applichem, Darmstadt, Germany).  
 
4.2.3.2.3 Elution 
Elution of the captured DNA was achieved by exposing the 2ml microtube containing the 
streptavidin coated paramagnetic beads in 100µl TE buffer to UV light (300-350nm) during 5 min. 
For this, a midrange trans illuminator can be used. After each minute the samples were mixed and 
vortex vigorously. To make the UV elution more convenient and to avoid possible health hazards 
related to the use of agarose gel trans illuminators (still often contaminated by the use of Ethidium 
Bromide), we designed an UV elution chamber fitted with a broad spectrum UV lamp with a wave 
length between 305 and 315 nm (PL-S 9W/12/2P, Philips, Brussels, Belgium) in which 1.5ml 
microtubes fit (distance to the lamp 2cm), hereon we will refer to the lamp as UVb.  After exposure, 
the 2 ml microtube was placed on a magnetic rack to retain the beads and the supernatant containing 
the released DNA was transferred to a new 1.5 ml microtube and conserved at -20°C until further 
testing. 
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4.2.3.3 Detection of the Target DNA (qPCR) 
The purified DNA extract was analysed as described before (De Craeye et al., 2011). Briefly, 10µl of 
the DNA extract was tested in a final reaction volume of 25µl containing 12.5µl of ExTaq 2X probe 
mix (Takara, Saint-Germain-en-Laye, France), 400nM of primers T2 and T3, 200nM of primers VF1 
and VR1, 66nM of probe TP and 40nM of probe VP. All stock solutions of the primers and probes 
were made in TE buffer pH8.0 (Applichem, Darmstadt, Germany). To check for inhibition and 
possible competition between the PCR targets each DNA sample was tested twice in each PCR run: 
once in duplex (D), testing for the presence of T. gondii DNA and cellular r18S; and once in simplex 
(S) with only the primers and probes to amplify the T. gondii target (without VF1, VR1 and VP). The 
real-time PCR was performed on a BioRad CFX 96 thermocycler (Hercules, California, USA) with 
the following 2-step cycling program: an initial DNA denaturation and Taq polymerase activation of 
3 min. at 95°C, followed by 41 cycles of 15s at 95°C and annealing/extension of 20s at 60°C. In each 
PCR run non-template controls were included. The qPCR results were analysed using the BioRad 
CFX manager software to obtain the crossing point (Cp) values. 
 
4.2.2.4 ISO 17025 Validation 
To investigate the reliability of the MC-qPCR, a method validation according to the ISO 17025 
standard was performed. For this, the following parameters were assessed: repeatability, intra-
reproducibility, inter-reproducibility (2° and 3° line control tests), cross-contamination, selectivity, 
limit of detection (LOD), cross reactivity, specificity and sensitivity. The specificity and sensitivity 
were assessed on tissues collected from experimentally infected pigs tested with both MC-qPCR and 
bio-assay (gold standard method). 
 
4.2.5 Experimental Infections in Pigs 
To study the specificity and sensitivity of the method, ten 3-week old T. gondii seronegative piglets 
(confirmed by 2 different serological methods: the modified agglutination test (ToxoScreen DA, 
Biomérieux, Capronne, France) and an in house immunofluorescence test (based on Toxo-Spot IF, 
Biomérieux, Capronne, France) (Verhelst et al., 2015)  were purchased and divided into groups 
according to the following experimental setup: group 1, two negative control animals; group 2, four 
animals infected with 6000 tissue cysts of the T. gondii IPB-G strain (oral inoculation); group 3, four 
animals infected with 6000 tissue cysts of the T. gondii IPB-LR strain (oral inoculation). For this an 
inoculum prepared from brain homogenate from previously infected mice was prepared and 
quantified by counting the number of tissue cysts with a phase contrast microscope (dark field 
setting, 100X amplification).  
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The piglets were separated in different stables according to groups, observed daily and a humane-
endpoint was defined to limit the suffering of the animals in case of disease and also serologically 
monitored weekly to confirm an established infection in the positive animals and to monitor the 
absence of it in the negative animals. Four months post infection (p.i.), the pigs were euthanized 
using Sodium pentobarbital (Iv) and the following tissues were collected: heart (Ha), M. 
gastrocnemius (Ga), M. psoas major (PM), M. longissimus dorsi (LD), diaphragm (DI), M.  
intercostal (IC) and brain (BR).  
 
The collected tissues samples (except the brain tissue) were first cleaned by removing fats and 
connective tissues and then cut into small pieces (1cm
3
). The whole cut sample was then mingled 




Hundred grams of cut tissue were homogenized in a blender with 150 ml sterile saline (0.9 % NaCl) 
supplemented with 0.25% trypsin (Gibco) and gentamycin (0.4mg/ml). The homogenate was then 
transferred to a 2l flask and incubated in a water bath at 37°C for 1h 45 min under continuous stirring 
(magnetic stirrer). The digest was then filtered through a gauze, transferred to a 500 ml centrifuge 
bottle and centrifuged at 2100 g at RT for 20 min.  
 
The supernatant is then removed and the pellet resuspended in 100 ml of saline with gentamycin and 
centrifuged at 2100 g at room temperature for 15 min. This step was repeated once more in order to 
remove most of the trypsin present in the pellet. The final pellet was then resuspended in 10 ml of 
PBS supplemented with gentamycin and IP injected into 5 Swiss white female mice, 1ml each 
(Ethics committee licence n: 20140704-02).  
 
The mice were observed daily and a humane-endpoint was defined to limit the suffering of the mice 
in case of disease. In this case, the mice were euthanized and the lungs and, if present, ascites from 
the peritoneal cavity were collected and tested in PCR as described before (Verhelst et al., 2015). Six 
weeks after the inoculation, the mice were euthanized and their blood recovered to prepare serum. 
The sera were tested by an indirect immunofluorence assay (IFA) as described before (Verhelst et 
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4.2.7 Statistical Analysis 
For determining the LOD, a generalized linear model was fit between detection rates and initial 
concentrations to obtain the relation between concentration and detection rate using a PROBIT link.  
The concentration that corresponds with 95, 96, 97, 98 and 99% detection rates was calculated and 
confidence intervals around this concentration were obtained by means of a 1000-fold bootstrap. 
 
The Cohen's kappa coefficient measures inter-rater agreement for qualitative (categorical) items, this 
statistical analysis was used to compare the results obtained with the two direct methods used on this 
study (bioassay and MC-qPCR). The data analysis was performed with the Richard Lowry 1998-
2016 software available on the VassarStats website for Statistical Computation 
(http://vassarstats.net/kappa.html). 
4.3 Results 
4.3.1 Optimization of the MC-qPCR 
4.3.1.1 Removal of Free Biotin 
Biotin naturally present in the tissue lysate will reduce the sensitivity of the detection as it will 
preferably bind to the streptavidin coated magnetic beads. It is therefore essential to insert a biotin 
removal step before adding the biotinylated capture probes as described by (Opsteegh et al., 2010). 
The biotin removal was achieved by using streptavidin coated agarose beads. 
 
To investigate the effect and the amount of streptavidin agarose beads needed, the magnetic capture 
was tested under different conditions: on a reference sample (performed with 50µl of beads), a 
capture “blocked” sample (using beads exposed to an excess of biotin prior to the capture procedure) 
and a series of samples supplemented with an increasing amount of biotin (0, 1, 3, 4, 6 and 10 nm). 
All obtained samples were then tested in qPCR and the obtained Cp values were compared.  
 
The Cp value of the reference sample can be considered as an optimal capture, as no more free biotin 
should have been present during the capture process, while the capture “blocked” sample shows what 
happens when the paramagnetic beads have been exposed to an excess of biotin, thus being restricted 
in their capacity to capture the biotinylated probes. A clear negative effect, as measured by higher Cp 
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Supplementary Table S4.1. Magnetic capture real time PCR (MC-qPCR):  effect of free biotin in 













rep1 rep 2 Average 
10*E4 0 nmol 50 µl ok 27.44 27.39 27.42 
10*E4 10 nmol 50 µl ok 27.42 27.43 27.43 
10*E4 1 nmol 10 µl ok 29.18 29.05 29.12 
10*E4 3 nmol 10 µl ok 29.59 29.49 29.54 
10*E4 4 nmol 10 µl ok 29.90 29.98 29.94 
10*E4 6 nmol 10 µl ok 31.10 30.86 30.98 
10*E4 10 nmol 10 µl ok 31.69 31.94 31.82 
10*E4 0 nmol 50 µl Blocked  30.16 30.23 30.20 
a
 Concentration of tachyzoites spiked to the sample 
b
 Magnetic beads previously incubated with free biotin to block the binding sites (blocked) or not blocked (ok) 
nmol, nanomol; rep 1, replicate 1; rep 2, replicate 2.  
 
 This confirmed that indeed the presence of free biotin is detrimental for the sensitivity of the 
method. Therefore, the use of 50 µl of Streptavidin agarose beads per sample was selected as a 
precautionary measure taking into account the unknown variability in biotin concentration due to the 
matrix effect and even within animal-level factors.  
 
4.3.1.2 Optimization of the Capture Process 
4.3.1.2.1 r18S Co-capture 
The co-capture of cellular r18S was used as a non-competitive internal amplification control 
(NCIAC). Therefore, different concentrations of the specific biotinylated capture probes (from 2x10
5
 
to 20 attomols/ml of biotin-free extract) were tested on samples with and without the addition of T. 
gondii DNA. The goal was to have a NCIAC qPCR result, which does not handicap the capture and 
amplification of the T. gondii target while obtaining stable, highly reproducible inter-sample Cp 
values.   
 
Indeed, a decrease of the concentration of the r18S capture probes also reduced the recovery of 
cellular r18S DNA, resulting in an increase of the Cp value. After analysis of the data, 20 attomols 
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4.3.1.2.2 Toxoplasma gondii DNA Capture 
In order to maximize the robustness of the T. gondii DNA capture process, various parameters 
related with the capture probes were investigated. First, to match the magnetic capture with the 
previously published and already ISO 15189 validated qPCR at the laboratory (De Craeye et al., 
2011), a new reverse probe was selected (see table 4.1).  
 
Then, as the probes were designed with an UV cleavable spacer, the effects of the presence of the 
capture probes in the qPCR reaction were investigated. For this, two experiments were designed. 
(Here, the DNA extracts resulting from the magnetic capture were only tested for the presence of 
T. gondii DNA, thus without the NCIAC): In the first experiment, qPCR reactions were performed 
using the capture probes as primers (no other primers added). This experiment confirmed the capture 
probes are used as primers in the qPCR reaction. Agarose gel electrophoresis confirmed the presence 
of the expected extended amplicon of the T. gondii DNA target. Secondly, to exclude any 
interference of the presence of the capture probes on the efficiency of the qPCR detection, a series of 
MC-qPCR tests were performed using capture probes in which the Thymine was replaced by Uracil 
bases. By including an initial UNG degradation step (Thermo Fisher Scientific) just before the start 
of the qPCR cycling protocol (37°C for 10 min., following the manufacturer’s instructions), those 
Uracil containing captures were destroyed and amplification products were solely synthetized using 
the PCR primers. Our results indicated that indeed the captures were used in the qPCR reaction, but 
without interference. The curves showed the same efficiency in all the experiments (data not shown).  
 
As the concentration of the capture probes in the magnetic capture is of paramount importance (a 
maximum of target DNA has to be hybridized, without having an excess of probes competing for 
binding to the beads) a series of experiments with two different concentrations were tested (1 pmol 





 and 10 tachyzoites/12ml of lysate). The obtained qPCR results for both probe 
concentrations showed little or no difference (data not shown). Hence, the concentration of 1 pmol 
per ml of biotin-free lysate was selected for further experiments. 
 
Once the optimal concentration of all the capture probes was known all the capture probes were 
combined into a single 1000 times concentrated Capture Mix (CM). Aliquots were stored at -20°C. 
No difference was seen in the qPCR results using 10µl of CM per 10ml of meat lysate or by adding 
each probe separately (supplementary Table S4.2). The use of the CM was selected for the further 
optimization and validation of the method. 
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Supplementary Table S4.2. Magnetic capture real time PCR (MC-qPCR): combination of all the 
capture probes in one mix  
 
  
Capture Mix Separated captures 
Toxoplasma gondii rep 1 23.33 Cp 23.33 Cp 
rep2 23.34 Cp 23.34 Cp 
Average 23.33 Cp 23.33 Cp 
r18S rep 1 18.27 Cp 18.55 Cp 
rep2 18.30 Cp 18.61 Cp 
Average 18.28 Cp 18.58 Cp 
rep 1, replicate 1; rep 2, replicate 2; Cp, crossing point. 
 
Finally, as the hybridization of the capture probes to the target DNA is a crucial step, different 
hybridization temperatures (45°C, 50°C, 55°C, 60°C and 65°C) after the initial denaturation at 95°C 
were tested. As no substantial difference was observed within the tested temperature range, we also 
tested the hybridisation process by incubating at RT for 15 min. Here, equal results were obtained 
(supplementary Fig. S4.1) showing that the hybridization is completed during the cooling down of 
the samples. We therefore selected 15 min. of hybridization time at RT in the final protocol, making 
the use of a hybridisation oven redundant. 
 
 
Supplementary Fig. S4.1. Optimization of the Magnetic Capture real time PCR and effects of different 
temperatures of hybridization on the probes with the target DNA.   
 
4.3.1.3 Streptavidin Coated Paramagnetic Beads 
Although expensive, the streptavidin coated paramagnetic beads are an essential reagent for the 
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method, we tested different concentrations of streptavidin paramagnetic beads (80, 40, 20, 10 and 5 
µg/ml of biotin-free lysate) to determine the lowest concentration that could be used without 
diminishing the sensitivity. Similar results were obtained for all tested concentrations (supplementary 
Table S4.3). The addition of more paramagnetic beads does thus not correspond with a higher 
recovery of target DNA. Therefore, 20µg (20 µl) of streptavidin magnetic beads per ml of biotin-free 
extract was selected as the amount to be used in all further experiments. 
 
Supplementary Table S4.3. Magnetic capture real time PCR (MC-qPCR): titration of Streptavidin 
coated paramagnetic beads (M. beads) 
 
  Concentration of M. beads (µg/ml) 
  40 20 10 5 0 
Toxoplasma 
gondii 
rep 1 34.28 Cp 34.1 Cp 35.7 Cp 35.49 Cp - 
rep 2 34.25 Cp 33.67 Cp 34.33 Cp 34.51 Cp - 
Average 34.27 Cp 33.89 Cp 35.02 Cp 35.00 Cp - 
rep 1, replicate 1; rep 2, replicate 2  
 
4.3.1.4 UV elution 
To prove the UVb elution is more efficient and convenient compared to elution based on thermal 
denaturation, the methods were compared. For this, streptavidin coated paramagnetic beads that had 
been used to capture DNA from the same lysate were subjected to thermal elution (incubation in 
boiling water for 10min) or to UVb irradiation and the respective qPCR results were compared.  
When performing thermic release of the targets, inhibition was observed in the subsequent qPCR 
decreasing the sensitivity of the method. On the other hand, using UVb elution, no inhibition was 
observed and thus higher sensitivity was obtained (Table 4.2). 
 
Table 4.2. Comparison of the two elution methods used with magnetic capture real time PCR (MC-qPCR): 
UVb-mediated and thermic elution.  
Method  UVb   Thermic
b 
Sample Negative  Positive  Negative  Positive 
 Eluate dil
a 
1:1 1:10 1:100  1:1 1:10 1:100  1:1 1:10 1:100  1:1 1:10 1:100 
T. gondii N/A np np  33.41 np np  N/A
c 





r18S 20.31 np np  20.22 np np  Inh
c 
23.43 30.48  30.07
c
 23.87 27.48 
N/A, target not amplified; np, not performed.  
a Dilution (dil) at which the obtained eluate was tested with qPCR.  
b Incubation at 100°C for 10 min. 
c Those qPCRs showed inhibition either due to the absence of an amplification signal for the non-competitive internal amplification control (NCIAC), 
or due to a poor observed PCR efficiency. 
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4.3.1.4.1 UVb Exposure Time 
To determine the optimal time of UVb exposure, the following experimental setup was designed: a 
positive meat sample (spiked with high numbers of tissue cysts) was processed following the MC-
qPCR procedure till the washing step. After the last washing, the beads were resuspended in 100µl 
elution buffer and exposed to UVb for one minute. The tube was then placed on the magnetic rack 
and the eluate recovered. This elution step was repeated 5 more times, so six consecutive eluate 
fractions were obtained and each was tested separately in qPCR. The experiment was performed 
twice in order to estimate variability. 
 
In order to estimate the contribution that every additional minute of UVb exposure would have on 
the final Cp result (Cpfinal), the following formula was applied: 








Cpfinal  : the final Cp value obtained after n minutes of UVb exposure. 
Cpref : the Cp obtained after the first minute of UVb exposure. 
i : represents each minute of UVb exposure, of a total of n minutes. 
∆𝐶𝑝𝑖 =  𝐶𝑝𝑖 − 𝐶𝑝𝑟𝑒𝑓: the Cp obtained after i minutes of exposure minus 𝐶𝑝𝑟𝑒𝑓 . 
Au1: represents an arbitrary amount of DNA released from the beads. As we cannot know at this point how much DNA 
is actually captured, nor the amount of DNA eluated, we attributed to the latter an arbitrary value. In the hypothesis most 
of the DNA is released after the first minute of UVb exposure, the arbitrary value at that time point was set to be 1. 
 
As hypothesized, the results show that most of the DNA is eluted after the first minute of UVb 
exposure, as the eluate at this time point has the lowest Cp values for both r18S and T. gondii (Table 
4.3). Considering the contributions of each additional minute of UVb elution, after 5 minutes there is 
no more significant contribution to the final Cp values. Five minutes of UVb exposure was thus 
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cont. to Cp 
Cpfinal 
1 33.81 Cpref  1  33.81 33.81   34.46  Cpref  1  34.46 34.46 
2 34.37 0.56 1.68 -0.74 33.06   34.08 -0.38 2.3 -1.2 33.26 
3 35.82 2.01 1.25 -0.32 32.74   35.83 1.37 1.4 -0.47 32.79 
4 37.08 3.27 1.1 -0.14 32.60   36.49 2.03 1.3 -0.316 32.47 
5 37.41 3.6 1.08 -0.11 32.49   36.89 2.43 1.2 -0.25 32.22 
6 38.04 4.23 1.05 -0.07 32.41   38.3 3.84 1.1 -0.098 32.12 
𝐶𝑝𝑓𝑖𝑛𝑎𝑙 , the final Cp value obtained after 𝑛 min of UV exposure; I, each min of UV exposure for a total of n min; 
𝐶𝑝𝑟𝑒𝑓, the Cp obtained after 1 min of UV exposure; ∆𝐶𝑝𝑖 =  𝐶𝑝𝑖 − 𝐶𝑝𝑟𝑒𝑓 , the Cp obtained after i min of exposure minus 𝐶𝑝𝑟𝑒𝑓; Au, 
an arbitrary amount of DNA released from the beads, here set to be equal to 1 for the reference (the first minute of exposure). 
 
 
4.3.2 ISO 17025 validation 
To test the robustness of the MC-qPCR method and to be able to apply it for diagnostic purposes, an 
extensive ISO 17025 validation was performed. An overview of the results obtained during the 
validation is shown in Table 4.4. 
 
Table 4.4. Overview of the results obtained by the magnetic capture real time PCR (MC-qPCR) during the 
ISO 17025 validation. 
Parameter Results Conclusion 
Repeatability 1.13% CV OK 









Cross-contamination No cross contamination measured when alternating positives and negatives OK 
Selectivity BLAST OK 
LOD 
Cyst 
1 /100g of meat 
Tachyzoites 























Specificity 100 % OK 























CV, coefficient of variation; OK, satisfactory results; LOD, limit of detection; Pos, positive; Neg, negative; T. gondii, 
Toxoplasma gondii; S. Auch, Sarcocystis aucheniae; S. meis, Sarcocystis meischeriana; S. cruzi, Sarcocystis cruzi; NMC, 
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4.3.2.1 Matrix effect 
As the performance of a DNA extraction method can vary greatly depending on the matrix, the effect 
of the latter on the MC-qPCR method was assessed. Hundred grams of various types of tissues 
(brain, muscle, heart, lung, liver) were obtained from seronegative pigs, spiked with 5000 tachyzoites 
and tested with the MC-qPCR method. Also, meat samples from different species (pork loin, chicken 
breast, leg of lamb, beef and horse steak) were tested at the same concentration of tachyzoites and no 
matrix effect was observed (Table 4.4). 
 
4.3.2.2 Repeatability and Cross-contamination 
To study the repeatability of the method, 5 samples (100g of meat) were spiked with the same 
number of tachyzoites (10
5
 tachyzoites) and processed in parallel and in alternation order with 
negative control samples (NMC) to investigate the possibility for cross-contamination.  
 
The results show that the method is highly reproducible with a Coefficient of Variation (CV) of 
1.13% (Table 4.4). A CV lower than 3% is accepted for a qPCR detection method according to the 
consulted literature (Estes and Sevall, 2003; Moens et al., 2009). Also, no false positive results were 
obtained demonstrating that the method as performed (with all pre-emptive measures, from the 
sample reception till the qPCR result) was indeed free of cross contamination.  
 
4.3.2.3 Intra- and Inter Reproducibility  
Different persons working in the same lab should obtain the same the results, anytime. To test this, 
two positive samples (spiked with 10
5
 tachyzoites) and two negative samples were processed in 
parallel at two different time points by two different operators. Both operators obtained comparable 
results with a CV < 5% (a CV < 10% is the acceptance inter-assay criteria according to the consulted 
literature) (Estes and Sevall, 2003; Moens et al., 2009). 
 
To test inter-reproducibility, a second line control was performed: 2 positive and 2 negative samples 
were prepared and tested blindly by 2 different operators, both operators reported the same results. 
Moreover, a third line control has been organized with the RIVM (Centre for Infectious Disease 
Control, National Institute for Public Health and the Environment, 16 Bilthoven, the Netherlands) 
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The selectivity and specificity of the method was assessed by analysing the biotinylated capture 
probes, the primers and the PCR detection probes using the NCBI BLAST tool in order to find 
correspondences with other closely related coccidian species. The blast results showed that the used 
oligos should be sufficiently selective for the detection of T. gondii, avoiding cross reaction with 
other close related species (Data not shown). 
 
To confirm the BLAST results and to test for possible cross-reactivity with closely related coccidian 
parasites, samples were spiked with DNA from Neospora caninum, Sarcocystis cruzi, Sarcocystis 
aucheniae and Sarcocystis meischeriana. Neospora caninum DNA was kindly provided by Dr. Frank 
Katzer from Moredun Research Institute, Edinburgh, UK; and the Sarcocystis spp. DNA from Dr. 
Gastón Moré from the National University of La Plata, Argentina. These samples were processed in 
parallel with a positive control of extraction for T. gondii (PMC) and a negative control of extraction 
(NMC). Only the T. gondii spiked sample showed an amplification in the qPCR, confirming the 
absence of cross-reaction with the tested closely related coccidian (Table 4.4). 
 
4.3.2.5 Limit of Detection  
To precisely determine the limit of detection (LOD) in terms of number of parasites present in 100g 
meat, samples spiked with different concentrations of tachyzoites (10 000, 5000, 1000, 500, 250, 
125, 100, 75, 50 and 25) were tested. The LOD was determined using PROBIT analysis on the 
obtained results. The lowest concentrations of tachyzoites at which 99% of the positive samples will 
test correctly was estimated to be 65.4 per 100g of meat (95% CI: 31.3-94.4) (Figure 4.1).  
 
Fig. 4.1. Box and whisker plots for Delta crossing point (Cp) values for different concentrations of 
Toxoplasma gondii tachyzoites (A) and tissue cysts (B). Upper quantiles for limit of detection (LODs) are 
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given with their estimated values and corresponding confidence intervals in (C) for the different tachyzoites 
concentrations. 
The LOD results show that, as in meat T. gondii is present in the form of bradyzoites encapsulated by 
hundreds in resistant tissues cysts, as little as one cyst per 100g of sample should always be detected. 
In order to confirm this, negative samples were spiked either with 1 small cyst (3 replicates), 1 big 
cyst (3 replicates) or 5 cysts (1 sample). All the samples were tested positive, confirming the LOD of 
the method as 1 cyst per 100g of meat (Figure 4.1 and Table 4.4). 
 
4.3.2.6 Specificity and sensitivity 
The specificity and sensitivity was assessed on tissues collected from pigs experimentally infected 
with either the T. gondii IPB-LR or T. gondii IPB-G strains. The collected tissues (heart (Ha), M. 
gastrocnemius (Ga), M. psoas major (PM), M. longissimus dorsi (LD), diaphragm (DI), M. 
intercostales (IC) and brain (BR)), were processed, homogenized and divided in two (except for the 
brain tissue): one part was then analysed with mouse bio-assay (considered as the reference method) 
and the other by MC-qPCR.  
 
The results obtained in both tests were then compared to calculate the specificity and sensitivity. The 
following criteria were applied in the analysis: 1. Samples from uninfected control pigs should 
always be negative. Here, any positive result in either method was thus considered as false positive. 
2. Samples from experimentally inoculated, seroconverted pigs can test either positive or negative. A 
sample was thus considered as true negative when testing negative in both methods, bioassay and 
MC-qPCR, whereas a sample was considered as a true a positive when it tested positive in either of 
the methods. Consequently, when for a given sample from an experimentally infected and 
seroconverted pig the MC-qPCR result was positive, while the bioassay result was negative, the 
latter was considered as a false negative, whereas inversely the MC-qPCR result was negative, while 
the bioassay result was positive, the former was considered as a false negative. 
 
The obtained results are summarized in Tables 4.4 and 4.5. Data analysis of the results yielded a 
100% specificity for both methods (MC-qPCR and Bioassay) and a sensitivity of (94.12% with a 
95% CI of 80.32 - 99.28) for MC-qPCR, higher compared to bioassay (86.49% with a 95% CI of 
71.23 - 95.46). Moreover, the Cohen’s Kappa ratio for both methods is 0.74 which implies 
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Table 4.5. Overview of mouse bioassay and the magnetic capture real time PCR (MC-qPCR) results obtained 
for muscle (100 g) and brain (50 g) samples from experimentally infected pigs. 







 2/3 2/3 2/3 3/3 3/3 np 
MC-qPCR 3/3 2/3 2/3 3/3 3/3 3/3 3/3 






Bioassay 4/4 1/4 3/4 3/4 3/4 4/4 np 
MC-qPCR 3/4 2/4 3/4 4/4 4/4 4/4 4/4 
g/test ±100 g ±100 g ±100 g ±100 g ±100 g ±100 g ±50 g 
Detected Bioassay 7/7 3/7 5/7 5/7 6/7 7/7 np 
Detected MC-qPCR 6/7 4/7 5/7 7/7 7/7 7/7 7/7 
Negative 
n=2 Bioassay 0/2 0/2 0/2 0/2 0/2 0/2 np 
MC-qPCR 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
g/test ±100 g ±100 g ±100 g ±100 g ±100 g ±100 g ±50 g 
Detected both methods 0/4 0/4 0/4 0/4 0/4 0/4 0/4 
a number of positive samples in function of the total number of samples. 
PM, psoas major; Ga, gastrocnemius; D, diaphragm; Ic, intercostal; LD, longissimus dorsi; Ha, heart; Br, brain; np, not performed; n, 
number of pigs. 
4.4 Discussion 
Although the introduction of PCR in the detection of T. gondii infection represented a step forward, 
it has been often proven insufficiently sensitive to detect T. gondii in meat (da Silva and Langoni, 
2001; Garcia et al., 2006). This lack in sensitivity is mainly due to a combination of the used DNA 
extraction methods (often commercially available kits) that are designed for small amounts of 
samples, with a (sometimes) very low T. gondii tissue cysts density in meat. It is thus mostly the 
preceding extraction that handicaps the otherwise very sensitive PCR methods. Apart from the 
possibility to isolate the infecting strain, this is the main reason why still today mouse bioassay is 
considered the most sensitive method after the cat bioassay only performed in short number of labs 
in the world (Dubey et al., 1998; Djokic et al., 2016).  
 
However, as the parasites must be viable to be detected by bioassay, bioassay can give false negative 
results when incorrectly conserved or stale samples are tested. Today, bioassay is more and more an 
ethically questionable method and implies a long experimental practice, the need of animal facilities 
conform to regulations and the huge associated costs, making it uneasy to implement the method for 
screening (food safety) purposes. There is thus a need for the development of an at least even 
sensitive and more easily implementable alternative.  
 
The previously published MC-qPCR method by Opsteegh et al, 2010, by hugely scaling up the 
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amount of sample from which DNA can selectively been extracted and by concentrating it into a 
volume testable in PCR, already represented a major step towards a sensitive and quantitative 
alternative to detect T. gondii in meat. For this, 100g of meat is completely lysed in order to release 
all the DNA. Then, by using selective biotinylated probes and streptavidin coated paramagnetic 
beads, the T. gondii DNA eventually present is concentrated into a very small volume and then tested 
in real-time PCR (Opsteegh et al., 2010).  
 
Still, as has been proven in the latest EFSA report (Opsteegh et al., 2016), some discordances 
continue to exist between the (Opsteegh et al., 2010) method and the mouse bioassay and even with a 
qPCR on trypsin digested tissues. Major differences in sensitivity were for example found in the 
described experimental studies in pigs: whereas 25.6 and 43.4% of the samples tested positive by 
mouse bioassay and qPCR respectively, only 16.9% were found positive by MC-qPCR. This can 
certainly in part be explained by the fact that the bioassay and the qPCR were performed on trypsin-
digested heart samples while frozen diaphragms were used for the MC-qPCR (EFSA, 2016).  
Nevertheless, some technical improvements to make the MC-qPCR more sensitive and robust were 
thus necessary.  
 
In this paper we present a modified and improved MC-qPCR for detecting T. gondii DNA in meat: 
we added a co-capture of the host’s cellular r18S as NCIAC, we made the DNA elution more 
efficient (UVb mediated release of the DNA from the paramagnetic beads), we reduced incubation 
times where possible, and we reduced the reagent costs by performing an extensive market screening 
and testing (e.g. the use of different paramagnetic beads, a very expensive reagent). Then, after 
several rounds of optimization steps, the whole process was fully validated according to ISO 17025 
standards permitting its use as an accredited method.  
 
The robustness of the modified MC-qPCR method is clearly reflected in the results of the various 
parameters assessed during the validation process: the repeatability, intra- and inter reproducibility, 
cross-contamination, selectivity, the absence of cross reactivity and the broad range of matrices that 
can be tested. Furthermore, with a 99% LOD of 65.4 tachyzoites per 100g meat, a better detection 
limit was achieved compared to the original method (95% LOD of 227 tachyzoites per g sample). 
We also confirmed the detection limit of 1 tissue cyst per 100g sample by performing spiking 
experiments using purified tissue cysts.  
 
The specificity and sensitivity were investigated by comparing our modified MC-qPCR with the 
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mouse bioassay on tissues of experimentally infected pigs. Here, to obtain the best homogeneity, the 
whole organ or muscle tested from each animal was first cut into small pieces, mingled and then 
divided for each test. The modified MC-qPCR was able to detect a higher number of infected tissues 
(94.12%) compared to the bioassay (86.49%). These results are by far better compared to previously 
published results where the bioassay using mice remained the most sensitive method (Gamble et al., 
2005; Garcia et al., 2006; Gardner et al., 2010). Also, we obtained a calculated Cohen’s Kappa 
coefficient between the modified MC-qPCR and the bioassay of 0.74 (P< 0.005) indicating 
substantial agreement while in the recent EFSA report a Cohen’s kappa coefficient of only 0.36 was 
obtained comparing different matrixes (heart for mouse bioassay and diaphragm for MC-qPCR 
(Landis and Koch, 1977; Opsteegh et al., 2016).   
 
Although the combination T. gondii/pork meat has been ranked as second of pathogen-food 
combinations in function of QALYs and the costs of illness (Batz et al., 2012), toxoplasmosis in 
humans has been associated with the consumption of other livestock species in general. Moreover, a 
quantitative risk assessment performed in the Netherlands estimates that 68 % of the meat-borne T. 
gondii infections could actually be due to the consumption of beef and only 11% due to pork meat 
(Opsteegh et al., 2011). Furthermore, the predilection tissues for the detection of the parasite can 
vary from one livestock species to another: while heart has been described as the predilection tissue 
for sheep and pork, a recent publication suggests liver as a better tissue to demonstrate the presence 
of T. gondii in cattle (Opsteegh et al., 2016). In the current study, we have tested the most common 
livestock species and various matrixes confirming the wide-ranging applicability of the method. 
 
Our results demonstrate the potential of the modified MC-qPCR as a full alternative for the mouse 
bioassay for archetypal T. gondii strains (Type I, Type II, Type III), with the additional advantage of 
being quantitative, thus permitting the estimation of the parasitic load in various types of tissues. 
When the infecting T. gondii strain needs to be isolated for further studies, the viability of detected T. 
gondii needs to be demonstrated to better estimate the risk for the consumers. Also, the bioassay 
might still be necessary when working in areas such as, South America where atypical T. gondii 
strains prevail. Unfortunately, atypical strains such as MAS, TgCatBr9, VAND, RUB, TgCatBr5, 
present in South American countries, could not be experimentally evaluated during this study and 
special attention should be paid when working with samples originating from this areas since the 
high levels of polymorphism at the target locus could render the method less sensitive. 
 
 Here, in the spirit of reducing the number of experimental animals needed, a first screening with the 
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MC-qPCR could be performed and only positive samples would then be tested in bioassay.  
 
Based on the results of the validation and the comparison with the mouse bioassay, we can state that 
our enhancements to the MC-qPCR significantly improved this method, making it more robust, 
reliable and sensitive at a lesser cost.  
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Abstract 
Toxoplasma gondii is an ubiquitous apicomplexan parasite which can infect any warm-blooded 
animal including humans. Humans and carnivores/omnivores can also get infected by consumption 
of raw or undercooked meat containing cysts. This route of transmission is considered to account for 
at least 30% of human toxoplasmosis cases. To better assess the role of pork as a source of infection 
for humans, the parasite burden resulting from experimental infection with different parasite stages 
and different strains of T. gondii during the acute and chronic phases was studied. The parasite 
burden in different tissues was measured with a ISO 17025 validated Magnetic Capture-qPCR. A 
high burden of infection was found in heart and lungs during the acute phase of infection and heart 
and brain were identified as the most parasitized tissues during the chronic phase of infection, 
independently of the parasite stage and the strain used. Remarkably, a higher parasite burden was 
measured in different tissues following infection with oocysts of a type II strain when compared with 
a tissue cyst infection with either a type II or a type I/II strain. However, these results can have been 
affected by the use of different strains and euthanasia time points. The parasite burden resulting from 
a tissue cyst infection was not significantly different between the two strains.  
 
5.1 Introduction 
Toxoplasma gondii is an obligate intracellular cyst-forming coccidian parasite. Being worldwide 
prevalent and zoonotic, T. gondii is considered one of the most successful parasites (Halonen and 
Weiss, 2013). It has a complex life cycle: it can infect virtually any warm-blooded animal 
(intermediate host), while the sexual replication only takes place in the gastrointestinal tract of the 
definitive hosts, which are domestic and wild Felidae (Tenter et al., 2000). 
 
The life cycle in the intermediate host, including man, is characterised by an acute phase involving 
fast asexual intracellular replication of tachyzoites in almost all tissues, followed by a chronic phase 
involving the development of tissue cysts containing bradyzoites, mainly in the central nervous 
system and in skeletal muscles, which may persist lifelong (Dubey, 2010). Different infection routes 
have been demonstrated: 1. Consumption of meat from a chronically infected animal; 2. Ingestion of 
sporulated oocysts (resulting from the sexual replication in felids) via contaminated water, soil or 
vegetables; 3. Vertical transmission through the placenta (Opsteegh, 2016).  
 
The consumption of raw or undercooked T. gondii infected meat is considered a main route of 
transmission for humans (Cook et al., 2000): in developed countries 50% of the infections are 
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estimated to be meatborne (Scallan et al., 2011) and pork is considered to account for 41 % of 
foodborne human toxoplasmosis cases in the USA (Batz et al., 2012).   
 
The presence of anti-toxoplasma antibodies and direct detection of the parasite in different tissues 
have been widely used in different animal species for the demonstration of a T. gondii infection 
(Tenter et al., 2000; Dubey, 2010). The development of a Magnetic Capture qPCR (MC-qPCR) 
enables reliable parasite quantification in contrast to the qualitative results obtained with bioassays 
and classic PCR. As such, the MC-qPCR allows the study of the quantitative distribution of the 
parasite through the carcasses in different animal species (Opsteegh et al., 2010; Juránková et al., 
2013; Hosein et al., 2016; Aroussi et al., 2015), and the assessment of the risk of infection for the 
consumer of the different animal tissues. In pigs, the parasite burden has been studied following 
experimental infection with either oocysts (Opsteegh et al., 2010; Juránková et al., 2013) or tissue 
cysts (Verhelst et al., 2011; Jennes et al., 2017), but the potential effect of different parasite stages on 
the parasite burden is not known. In the definitive host, ingestion of oocysts has been demonstrated 
to be less efficient than ingestion of tissue cysts to induce infection. Hence, the infectious stage 
inducing infection in pigs may have an impact on the parasite burden of the tissues. In addition, the 
parasitic load has been shown to be strain dependant with a more pronounced clearance of the 
parasite in some tissues when using a hybrid Type I/II strain (T. gondii ISP-Gangji) than using a 
classical type II strain (Verhelst et al., 2011; Jennes et al., 2017). 
 
The aim of this study is to use the recently upgraded and ISO 17025 validated MC-qPCR (Gisbert 
Algaba et al, 2017) to study the potential effect of different parasite stages (oocysts and tissue cysts) 
and different strains (Type II and Type I/II strains) on the parasite burden in pigs during acute and 
chronic infections. By comparing the parasitic loads of different tissues under different conditions, 
the role of pork as one of the main sources of infection for humans can be better assessed.  
 
5.2. Materials and Methods 
5.2.1 T. gondii strains 
In order to study the most prevalent T. gondii genotype in Europe (Type II), the following strains 
were used: T. gondii IPB-LR (tissue cysts) (type II, low virulence in mice), T. gondii IPB-Gangji 
(tissue cysts) (Type II/I, a rare hybrid strain, virulent in mice) and T. gondii Tg-SweF2 (oocysts) 
(type II, low virulence in mice). The strains were genotyped by the Center of Biological Resources 
(Limoges, France) as described by Ajzenberg, et al. (2010). 
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5.2.1.1 Preparation of Tissue Cysts  
Swiss white outbred mice (Janvier Labs, Rennes, France) were intraperitoneally inoculated with the 
T. gondii IPB-LR (type II) or IPB-G (Type II /I) strains. After 6 weeks of incubation, the mice were 
euthanized and their brains were collected and homogenized in PBS supplemented with penicillin 
and streptomycin using a potter homogenator. The concentration of tissue cysts was determined by 
counting three times a volume of 8µl with a phase-contrast microscope. 
 
5.2.1.2 Isolation, purification and preparation of oocysts 
In order to perform an experimental infection with oocysts, feces from a cat naturally infected with 
the T. gondii Tg-SweF2 strain were obtained from the National Veterinary Institute of Sweden 
(SVA, Uppsala, Sweden). The oocysts were first isolated with sucrose flotation followed by a 
Caesium Chlorine gradient as described by Staggs et al. (2009). Briefly, the feces were homogenized 
with MilliQ water and 0.2% Tween®20, the suspension filtered through gauze and centrifuged. 
Subsequently, the pellet was resuspended in a sucrose solution (d:1.15 g/ml) and centrifuged at 800 g 
for 10 min. The supernatant containing the oocysts was carefully transferred to a new 50 ml 
Polypropylene tube and the sucrose washed away. Subsequently, the oocysts were aerated in 2% 
H2SO4 and at 22°C for 7 days to allow sporulation. Once sporulated, a Caesium Chlorine gradient 
was applied and the oocyst suspension was stored in 2% H2SO4 at 4°C till further use. 
 
The purified oocyst suspension was quantified using a Bürker counting chamber and a phase contrast 
microscope and diluted accordingly to obtain a final concentration of 10
5 
sporulated oocysts per 5 ml 
in PBS, supplemented with penicillin/streptomycin. 
 
5.2.2 Experimental Infections in Pigs 
5.2.2.1 Acute phase 
To study parasite distribution and load in the acute phase, 36 three-week old T. gondii seronegative 
piglets (confirmed by the modified agglutination test (MAT, ToxoScreen DA, Biomérieux, 
Capronne, France) and an in house immunofluorescence test (IFT, based on Toxo-Spot IF, 
Biomérieux, Capronne, France)) (Verhelst et al., 2015)) were divided into three groups according to 
the following experimental setup: group A1, 15 animals orally infected with 6000 tissue cysts of the 
T. gondii IPB-LR strain; group A2, 15 animals orally infected with 6000 tissue cysts of the T. gondii 
IPB-G strain; group A3, six negative control animals. 
 
Three animals from each experimental group (groups 1 and 2) were killed after 2, 4, 8, 14 and 28 
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days post infection. The piglets were serologically monitored by IFA as described by (Verhelst et 
al.,2015) and the heart (Ha) and lungs (Lu) were collected and tested with MC-qPCR. 
 
5.2.2.2 Chronic phase 
To study the chronic phase, 13 three-week-old T. gondii seronegative piglets (confirmed by two 
different serological methods: MAT and IFT (Verhelst et al., 2015)) were divided into four groups 
according to the following experimental setup: group C1, two negative control animals; group C2, 
three animals orally infected with 6000 tissue cysts of the T. gondii IPB-LR strain; group C3, four 
animals orally infected with 6000 tissue cysts of the T. gondii IPB-G strain; group C4, three animals 
orally infected with 10
5
 oocysts of the T. gondii Tg-SweF2 strain (Table 5.1). Hundred thousand 
oocysts (10
5
 * 8 sporozoites) and 6000 tissue cysts (6000 * >100 bradyzoites) were inoculated in 
order to infect pigs with a similar number of parasites.  
 
Table 5.1: Overview of the different experimental animal groups 











A1 15 6000 tissue cysts Bradyzoites LR (Type II) 
A2 15 6000 tissue cysts Bradyzoites Gangji (Type II/I) 
A3 6 na
 












C1 2 na na Control group 
C2 3 6000 tissue cysts Bradyzoites LR (Type II) 
C3 4 6000 tissue cysts Bradyzoites Gangji (Type II/I) 
C4 3  10
5
 oocysts Sporozoites Swe2 (TypeII) 
 
na: not applicable. 
 
The piglets were serologically monitored weekly from day 0 till euthanasia to confirm an established 
infection in the positive animals and to monitor the absence of infection in group C1. The pigs were 
euthanized 90 days post infection (dpi) in group C4 and between 130 and 182 dpi in groups C2 and 
C3. The following tissues were collected: heart (Ha), lungs (Lu), m. gastrocnemius (Ga), m. psoas 
major (PM), m. longissimus dorsi (LD), diaphragm (DI), m. intercostales (IC) and brain (BR).  
 
The collected tissue samples (except the brain tissue) were first cleaned by removing fats and 
connective tissues and then cut into small pieces of 1cm
3
.  
5.2.4 MC-qPCR  
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In order to determine the parasitic load, the MC-qPCR was performed as described by (Gisbert 
Algaba et al., 2017). In brief, the meat samples were homogenized in the presence of lysis buffer 
(100 mM Tris HCL, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 40mg/l proteinase k (30 mAnson-
U/mg; Amresco, Ohio, USA), pH = 8.0 ± 0.2) with a pedal homogenator (Labconsult, Brussels, 
Belgium) and lysed overnight at 55°C. Fats and cell debris were then removed by centrifugation and 
the free biotin possibly present in the crude extract was removed by adding streptavidin coated 
agarose beads (binding capacity >330 nmol/ml; solulink, San Diego, USA).  
 
The specific biotin labelled probes against the T. gondii 529bp RE (accession number: AF146527) 
and cellular r18S DNA were added to the biotin-free lysates and the samples were first denatured at 
95 °C followed by an incubation at room temperature in order to hybridize the probes with the 
complementary target sequences. After hybridization, the biotin labelled probes bound to the target 
DNA were captured using streptavidin magnetic beads (binding capacity > 2.5 nmol/mg (Solulink, 
San Diego, USA) and after washing and re-suspension in elution buffer, the target DNA was released 
from the beads by exposure to UV light. 
 
Finally, the qPCR was performed on the final DNA extract to detect the presence of T. gondii DNA 
and the results analysed using the BioRad CFX manager software to obtain the crossing point (Cp) 
values. 
 
5.2.5 Statistical Analysis 
All the samples with an exponential-amplification curve crossing the threshold (Cp) were considered 
positive for T. gondii, samples with no amplification curve for the T. gondii target but amplification 
of the NCIAC (Not Competitive Internal Amplification Control) were considered negative. As 
described in Gisbert Algaba et al. (2017), the limit of detection of the method is 65.4 parasites per 
100 g of tissue. For each round of samples a positive control with a known number of parasites 
(calibrator) was performed to correct for possible deviations due to manipulation errors. The number 
of parasites (n° p) was calculated according to the following formula: 




The formula resulted from a standard curve established with known concentrations of parasites 
ranging from 100 to 10
5 
spiked in 100g of tissue.  
 
A linear model was fit to look for the differences between the groups to be compared after a log10-
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transformation of the parasitic load.  Restricted maximum-likehood estimates were calculated taking 
into account the non-detects, which were modelled as '<log(LOQ)'.  Model estimates and their 
variance-covariance matrix were used to set up contrasts to compare infection types per tissue, 
tissues per parasite stage types and days.  P-values for each contrast were corrected according to 
Sidak in order to set the global type I error rate at 0.05.   The normal distribution of the residuals was 




5.3.1 Acute phase 
All the animals in groups A1 and A2 seroconverted and showed some mild clinical signs such as, 
fever, apathy and anorexia during the first week after infection.  
Regarding the comparison between the two strains used (LR and Ganji) at the level of parasitic loads 
during the acute phase of infection, statistical analyses could not be performed due the number of 
negative values. The results of the acute phase are presented in Figures 5.1 and 5.2, for the lungs and 
hearts, respectively.  
 
5.3.1.1 Lungs 
During the acute phase of infection, at day 2 post-infection (dpi) T. gondii was already present in the 
lungs of 2 out of 3 animals of both infected groups (A1 and A2). At 8 dpi the concentration of 
parasites reached a maximum and the parasite was found in all the tested animals for both groups 
(A1 and A2) while the parasite burden decreased slowly in the following days (14 and 28) (Figure 
5.1).  
 




Fig. 5.1. Box and whisker plots for log (N° parasites/10g) in function of days after infection for lungs. A 
vertical pattern of the plots is used for the results of animals infected with the IPB-LR T. gondii strain (Type 
II) and a diagonal pattern of the plots is used for the results of animals infected with the IPB-Gangji T. gondii 
strain (Type I/II).   
 
5.3.1.2 Heart 
In the heart that has been previously described as the predilection tissue of the parasite in pigs 
(Opsteegh et al., 2010), the parasite was not found in any of the animals of the experimental groups 
(A1 and A2) at 2 dpi and only in 1 animal of the A1 group (A1:1/3) and 2 of the A2 group (A2: 2/3) 
at 4 dpi. In contrast to what was observed in the lungs, in hearts the median parasite burden remained 
stable after 8 dpi (P> 0.1) (Figure 5.2).  
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Fig.5. 2. Box and whisker plots for log (N° parasites/10g) in function of days after infection for hearts. A 
vertical pattern of the plots is used for the results of animals infected with the IPB-LR T. gondii strain (Type 
II) and a diagonal pattern of the plots is used for the results of animals infected with the IPB-Gangji T. gondii 
strain (Type I/II).   
 
5.3.2 Chronic phase 
All the animals in groups C2, C3 and C4 seroconverted and showed some mild clinical signs such as, 
fever, apathy and anorexia during the first week after infection. 
 
5.3.2.1 Infection with tissue cysts 
5.3.2.1.1 Type II strain (T. gondii IPB-LR) 
During the chronic phase, in the animals infected with tissue cysts of a classical Type II strain (group 
C2), the parasite was found in all the tested tissues in only one of the animals. In the other two pigs 
of this group (pig 1 and pig 3), the parasite was found in all the tissues of the animals except for the 
M. gastrocnemius in pig 3 and the diaphragm in pig 1 (Figure 5.3 and suppl. Table 5.1).  
 
The parasite burden was significantly higher in the heart when compared to the M. gastrocnemius 
(Ga), diaphragm (Di) and Intercostal muscles (Ic) (P< 0.05), but not compared to the M. psoas major 
(PM) and M. longissimus dorsi (LD). The highest T. gondii concentration was found in the brain, 
being significantly higher (P< 0.05) when compared to M. gastrocnemius, diaphragm,M. intercostal 
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and M. longissimus dorsi (Figure 5.3 and suppl. Table 5.1). When comparing heart and brain no 
significant difference was found between these two tissues. 
 
5.3.2.1.2 Type I/II strain (T. gondii IPB-G) 
The median parasite burden in the animals infected with a hybrid Type I/II strain (group C3) was not 
significantly different from those infected with the type II strain although they were consistently 
lower in all the tissues except for the Ic muscle. When comparing the different tissues of the Type 
I/II strain infected animals, the parasite burden was significantly higher in the brain and the heart (P< 
0.05) compared to PM, Ga and Di and Ga and Di. The highest parasite burden was found in the heart 
and not in the brain as it was found in the T. gondii IPB-LR experimentally infected group (Figure 
5.3 and suppl. Table 5.1).  
 
5.3.2.2 Infection with oocysts 
In the pigs infected with oocysts (group C4), the parasite was found in all the tissues of all the 
animals after 90 dpi. Additionally, the higher parasitic loads were also found in heart and brain as in 
the other two experimental groups (Groups C2 and C3) (Figure 5.3 and suppl. Table 5.1). 
 
Fig. 5.3. Box and whisker plots for log (N° parasites/10g) in function of different tissues. A vertical lines 
pattern of the plots is used for the results of animals infected with tissue cysts of the IPB-LR T. gondii strain 
(Type II), a diagonal lines pattern of the plots is used for the results of animals infected with tissue cysts of the 
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IPB-Gangji T. gondii strain (Type I/II) and a horizontal lines pattern of the plots is used for the results of 
animals infected with oocysts of the Tg-SweF2 T. gondii strain (Type II).   
 
5.3.3 Evolution of the parasite burden in heart and lungs during the acute and chronic phases of 
infection  
When comparing the results during the acute and the chronic phases of infection (A1 and A2 
compared with C2 and C3), in the lungs the parasite burden at day 182 after infection (chronic phase 
of infection: (C2 and C3) was significantly lower (P<0.05) compared to day 8 (acute phase of 
infection: (A1 and A2) confirming the decreasing trend of the parasite burden in lungs in function of 
time observed during the acute phase. In contrast, in the hearts, the parasite burden measured during 
the acute phase remained stable after 182 dpi in the chronic phase of infection. 
 
Supplementary Table 5.1: Overview of the MC-qPCR results obtained for muscle (100g) and brain 
(50g) samples from experimentally infected pigs during the chronic phase of infection. 
Strain/stages Pig N° method PM Ga Di Ic LD Ha Br 
IPB-LR strain/ 
Tissue cysts 




p. load 2.81 2.68 0 2.11 2.79 4.92 4.37 




p. load 2.68 1.58 3.44 1.22 3.24 3.87 4.70 
3 MC-qPCR 34.55 - 33.25 32.69 37.57 35.89
b 
29.83 
p. load 2.30 0 2.74 2.90 1.32 3.87 4.15 
IPB-G strain/ 
Tissue cysts 
1 MC-qPCR 33.83 - - 35.17 36.73 32.64
a 
31.85 
p. load 2.57 0 0 2.10 1.59 3.92 3.49 




p. load 2.22 2.37 1.77 2.84 2.76 3.66 3.89 




p. load 2.65 0.58 0.92 2.74 2.50 4.35 4.40 
4 MC-qPCR - - 33.39 37.65 36.42 33.88 33.31 
p. load 0 0 2.68 1.29 1.69 2.52 3.03 
 Detected Mc-qPCR 6/7 4/7 5/7 7/7 7/7 7/7 7/7 
T gSweF2/ 
Oocysts 




p. load 3.37 2.79 2.48 3.66 3.92 4.97 5.14 




p. load 3.85 3.39 2.59 3.36 3.55 5.00 5.66 




p. load 4.69 4.76 4.37 4.70 4.82 5.49 5.35 
 Detected MC-qPCR 3/3 3/3 3/3 3/3 3/3 3/3 3/3 
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a
: dill 1/10; 
b
: dill 1/100; 
c
: dill 1/1000; PM: psoas major; Ga: gastrocnemius; Di: diaphragm; Ic: intercostal; LD: longissimus 
dorsi; Ha: heart; Br: brain;
 a:
 number of positive samples in function of the total number of samples; p. load: log 10 (number 
of parasites per 10 g of tissue) ; -: negative result; np: not performed;  
 
5.4. Discussion and conclusion 
Pork is considered among the most important sources of T. gondii infection in humans (Batz et al., 
2012). Although several studies have demonstrated the presence of the parasites in different tissues 
(Dubey et al., 1984; Dubey et al., 1986; Opsteegh et al., 2010; Juránková et al., 2013), only few 
studies have quantified the parasitic burden in different tissues (Opsteegh et al., 2010; Juránková et 
al., 2013).  
 
In this study, for the first time, the parasitic load in the heart and the lungs was studied during the 
acute phase of infection following infection with tissue cysts. The heart and the lungs were selected 
for this study as a high parasite burden has been consistently described in the mouse and the pig 
models for these two tissues (Dubey, 2010; Dubey et al., 2012). The parasite was found earlier in the 
lungs than in the heart (2 dpi), but the parasitic load in this tissue decreased in time after reaching a 
maximum at day 8 post infection. Moreover, the lungs tested during the chronic phase of infection 
(182 dpi) showed very low or even no parasite presence in contrast to what was described by 
(Juránková et al., 2013) where lungs were found as the tissue with the second highest parasite 
burden. This difference can be explained by the earlier euthanasia of the infected animals at day 76 
after infection. 
 
On the other hand, in the heart tissue the presence of the parasite was demonstrated only from day 4 
after inoculation. Remarkably, no significant variation in parasite burden was found from day 8 till 
day 28 post infection. When compared to the chronic phase, no significant difference was found and 
the parasite burden remained stable in the heart till day 182 after infection. These results confirm the 
importance of the heart for demonstrating the actual presence of the parasite in seropositive pigs. 
Although there was a trend of lower parasite burdens in pigs infected with the type I/II strain 
compared to the type II strain, this difference was not significant.  
 
Considering the chronic phase of infection, the results of the present study are in agreement with 
previous studies identifying brain as the most infected tissue when the pigs are infected with oocysts 
(Opsteegh et al., 2010; Juránková et al., 2013). Overall, from all the tested tissues, heart and brain 
showed the highest parasitic loads and no significant difference was found between both tissues in 
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any of the experimental groups. These results contrast with those obtained by (Juránková et al., 
2013) where the parasitic load in heart tissues was significantly lower than in the brain. The 
difference could be explained by the lower dose used in their experimental infections (5000 oocysts). 
A dose effect has been previously described in mice and pigs showing a sigmoidal relation of the 
probability of infection in function of the infective dose (AFSSA, 2005). However, those studies do 
not give much information of the quantitative parasite burden in tissues after infection with different 
infective doses. A recent study used a quantitative analysis of the parasite burden in pig tissues in 
function of the infective dose employed. Strikingly, a lower parasite burden was shown in tissues 
after infection with a high dose of tissue cysts from the Gangji strain than with a lower dose, while 
no effect was observed between high and low dose of tissue cysts from the LR strain (Jennes et al., 
2017). However, these studies were performed using less sensitive and less accurate quantitative 
techniques.  
 
When comparing the parasitic load resulting from infection with tissue cysts, no significant 
difference was observed between the two strains used (T. gondii IPB-LR strain (type II) and T. 
gondii IPB-Gangji (type I/II). However, although not significant, a higher parasitic load was 
observed in all the tissues except for Intercostal muscles after infection with the classic type II strain 
compared to the hybrid type I/II strain. These results are in agreement with the previous studies using 
less sensitive techniques (Verhelst et al., 2011; Jennes et al., 2017).  
 
Dose-response studies performed in different animal models have been recently adapted to human T. 
gondii infections showing a clear effect of the parasite burden present in the tissues on the 
probability of acquiring the infection by the consumers (AFSSA, 2005; Guo et al., 2016). These 
results highlight the importance of accurate T. gondii quantitative data in the different tissues, since 
animals carrying a higher parasite burden in their tissues will represent a higher risk for the consumer 
than those with lower parasitic loads. In this study, we showed a higher parasitic load in all the 
tissues examined compared to previous studies (Opsteegh et al., 2010; Juránková et al., 2013), which 
can be explained by the higher sensitivity of the MC-qPCR and the infective dose used. Additionally, 
the pigs infected with oocysts (Group C4) had a significantly higher parasitic load in M. psoas major, 
M. gastrocnemius and M. intercostal compared to the pigs infected with tissue cysts (Groups C2 and 
C3). In general, the overall parasitic load in all the tissues was higher for animals infected with 
oocysts. These findings suggest a potential role of the transmission form on the parasite burden at 
slaughter age. However, special attention needs to be paid when analysing these results since the use 
of a different strain (Tg-SweF2) and the earlier euthanasia of the pigs infected with oocysts might 
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have also influenced the obtained parasitic loads. If confirmed, these findings indicate a higher 
parasite burden in pigs infected with oocysts than with tissue cysts, in contrast to what happens in the 
definitive host (Dubey, 2010; Dubey et al., 2012). 
 
In conclusion, our results demonstrate the presence of T. gondii in the different tissues of pigs 
(intermediate hosts) and confirm that heart and brain are the predilection tissues for the direct 
detection of the parasite during the chronic phase of infection, independently of the transmission 
form and strain. During the acute phase of infection, the lungs are highly infected and they may 
therefore be used to demonstrate a recent infection. Overall, all the studied tissues showed a potential 
presence of the parasite at slaughter age posing a risk of infection for humans and other intermediate 
hosts consuming these tissues. Additionally, the potential role of the parasite stage on the parasite 
burden is suggested. However, in order to confirm these findings more experimental infections are 
needed using the different parasite stages originating from the same T. gondii strain. Also, studies on 
the parasite burden of naturally infected animals need to be addressed to confirm the parasite burden 
in pigs exposed to different doses of infection. 
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Abstract 
Toxoplasma gondii is a worldwide prevalent, zoonotic parasite of major importance for public 
health, which can infect any warm-blooded animal species, including humans. Humans can get 
infected by consumption of meat from a chronically infected animal, by ingestion of sporulated 
oocysts (resulting from the sexual replication in felids) via contaminated water, soil or vegetables 
and by vertical transmission through the placenta. Infection through meat consumption is estimated 
to account for at least 30% of human toxoplasmosis cases in developed countries and more 
specifically pork is considered to be responsible for 41% of foodborne human toxoplasmosis cases in 
the US. To better assess the role of pork as a source of infection for humans, circulating strains in 
both humans and pigs were isolated to perform a molecular epidemiological study. In the present 
study, 15 hearts from 94 sampled, originating from pigs raised in organic farms tested positive by 
MC-qPCR of which 9 strains were isolated by mouse bioassay, demonstrating the presence of viable 
parasites in animals intended for human consumption. When genotyped and compared with the 
human strains isolated during 2015 and 2016, a highly related structured population was 
demonstrated. Overall, these finding demonstrate the presence of infectious parasites in pigs intended 
for human consumption and the potential flow of strains from pigs to humans, reinforcing the 
identification of pork as a potential risk for the consumers.  
 
6.1. Introduction 
Toxoplasma gondii is an obligate intracellular cyst-forming coccidian parasite considered one of the 
most successful parasites worldwide (Halonen and Weiss, 2013). T. gondii is a zoonotic pathogen 
with a complex life cycle: it can infect virtually any warm-blooded animal (intermediate host), while 
the sexual replication only takes place in the gastrointestinal tract of the definitive hosts, which are 
domestic and wild Felidae (Tenter et al., 2000). 
 
Different infection routes have been demonstrated: 1. Consumption of meat from a chronically 
infected animal; 2. Ingestion of sporulated oocysts (resulting from the sexual replication in felids) via 
contaminated water, soil or vegetables; 3. Vertical transmission through the placenta (Hide, 2016).  
The consumption of raw or undercooked T. gondii infected meat is considered a main route of 
transmission for humans (Cook et al., 2000): in developed countries 50% of the infections are 
estimated to be meat borne (Scallan et al., 2011) and pork is considered to account for 41 % of 
foodborne human toxoplasmosis cases in the USA (Batz et al., 2012).  Besides the wide spectrum of 
intermediate host and the various routes of transmission, T. gondii shows a very structured genetic 
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population in Europe and North America with three main lineages also referred to as archetypal 
strains (Types I, II and III). The T. gondii strains circulating in Europe are primarily archetypal and 
the type II strains are the most predominant in humans and livestock species (Dubey, 2010). 
However, no data are available on the genetic profile of the strains circulating in the Belgian human 
population or in any of the main livestock species.   
 
The aim of this study was to identifystrains circulating in both humans and pigs and perform a 
molecular epidemiological study comparing the isolated strains originating from both humans and 
pigs to better estimate the role of pork as one of the main sources of infection for humans and the 
possible flow of strains from pigs to humans.  
 
6.2. Materials and Methods 
6.2.1 Porcine Toxoplasma isolates 
In order to collect isolates circulating in pigs, a pilot study was designed with visits to a Belgian 
slaughterhouse where pigs originating from organic farms are slaughtered. Based on the preliminary 
results of a T. gondii seroprevalence study in Belgium in which the prevalence in organic farms was 
consistently higher than in intensive production systems (Jennes et al., unpublished results), all the 
samples were collected from a slaughterhouse specialized in organic pigs located in Malmedy 
(Wallonia, Belgium). A total of 92 pigs representing 17 Belgian organic farms were sampled during 
2016. First the pigs were serologically screened for Toxoplasma antibodies, then confirmation of the 
presence of the parasite in heart was done by MC-qPCR, whereafter the parasite was isolated in 
mouse (bioassay).  
 
6.2.1.1 Serological screening 
The cardiac fluid from the 92 pigs was evaluated using the modified agglutination test (MAT) for the 
detection of antibodies against T. gondii as described by the manufacturer’s instructions (Toxo-
Screen DA kit, Biomerieux). Briefly, the cardiac fluid samples were diluted in PBS at a 1/40 dilution 
and 25µl of each dilution was applied in a round bottom microtiter plate with 25µl 2-
mercaptoethanol at 0.2 mol/l. Subsequently, 50 µl of a 1/5 dilution of whole formalized tachyzoites 
in Bovine Albumin Borate Saline (BABS) (supplied in the kit) buffer was added, mixed for 1 minute 
on a plate mixer at 300 rpm and incubated overnight at room temperature. A negative and a positive 
control were both supplied by the manufacturer and consisted of goat serum. As an external control, 
positive and negative pig serum samples obtained from previous experimental infections were tested 
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on the same plate. 
6.2.1.2 Confirmation of the presence of the parasite by MC-qPCR  
In order to confirm the actual presence of the parasite and determine the parasitic load, the Magnetic 
capture real time PCR was performed as described (Gisbert Algaba et al., 2017). In brief, the meat 
samples were homogenized in the presence of lysis buffer (100 mM Tris HCL, 5 mM EDTA, 0.2% 
SDS, 200 mM NaCl, 40mg/l proteinase k (30 mAnson-U/mg; Amresco, Ohio, USA), pH = 8.0 ± 0.2) 
with a pedal homogenator (Labconsult, Brussels, Belgium) and lysed overnight at 55°C. Fat and cell 
debris were then removed by centrifugation and the free biotin possibly present in the crude extract 
was removed by adding streptavidin-coated agarose beads (binding capacity >330 nmol/ml; solulink, 
San Diego, USA).  
 
The specific biotin-labelled probes against T. gondii (accession number: AF146527) and cellular 
r18S DNA were added to the biotin-free lysates and the samples were first denatured at 95 °C 
followed by an incubation at room temperature in order to hybridize the probes with the 
complementary target sequences. After hybridization, the biotin labelled probes bound to the target 
DNA were captured using streptavidin magnetic beads (binding capacity > 2.5 nmol/mg (Solulink, 
San Diego, USA) and after washing and re-suspension in elution buffer, the target DNA was released 
from the beads by exposure to UV light. 
 
Finally, the qPCR was performed on the final DNA extract to detect the presence of T. gondii DNA 
and the results were analysed using the BioRad CFX manager software to obtain the crossing point 
(Cp) values. 
 
6.2.1.3 Isolation of the strains, mouse bioassay 
Hundred grams of cut tissue were homogenized in a blender with 150 ml sterile saline (0.9 % NaCl) 
supplemented with 0.25 % trypsin (Gibco) and gentamycin (0.4 mg/ml). The homogenate was then 
transferred to a 2 l flask and incubated in a water bath at 37°C for 1h 45 min under continuous 
stirring (magnetic stirrer). The digest was then filtered through gauze, transferred to a 500 ml 
centrifuge bottle and centrifuged at 2100 x g at RT for 20 min.  
 
The supernatant is then removed and the pellet resuspended in 100 ml of saline with gentamycin and 
centrifuged at 2100 x g at room temperature for 15 min. This step was repeated once more in order to 
remove most of the trypsin present in the pellet. Next the final pellet was resuspended in 10 ml of 
PBS supplemented with gentamycin and IP injected into 5 Swiss white female mice, 1ml each. 
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The mice were observed daily and a humane endpoint was defined to limit the suffering of the mice 
in case of disease (Ethics Committee licence no: 20140704-02). 
  
Six weeks after the inoculation, the mice were euthanized, their blood collected and tested by 
indirect immunofluorescence assay (IFA) as described by (Verhelst et al., 2015). The mice were 
observed daily and a humane-endpoint was defined to limit the suffering, in case of disease (the mice 
were euthanized, the lungs and, if present, ascites from the peritoneal cavity were collected and 
tested in qPCR). 
 
6.2.2 Human Toxoplasma isolates 
The genotypes of the 15 T. gondii isolates originating from cases of congenital toxoplasmosis in 
Belgium during 2015 and 2016 were obtained from the National Reference Center (NRC) for 
Congenital Infections.  
 
6.2.3 Genotyping 
All the isolates were genotyped as described by (Azjenberg, 2010). Briefly, T. gondii DNA was 
extracted from 200 µl of brain homogenate using the QIAamp DNA Mini Kit (Qiagen) according the 
to the manufacturer’s instructions. Once extracted, a multiplex PCR was performed to amplify 
different microsatellite (MS) markers located in different genes (Table 6.1). These markers are 
grouped in two different levels of discrimination: i) typing markers (TUB2, W35, TgM-A, B18, B17, 
M33, IV.1, and XI.1) able to discriminate between the main T. gondii genotypes (I, II and III); ii) 
fingerprinting markers (M48, M102, N60, N82, AA, N61, and N83) with a high discrimination power 
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Table 6.1: Overview of the different microsatellites genotyping levels 
Discrimination level Marker Location
a
 
Typing level : 
 






















Location of the markers in the reference strain TgME49 
 
6.2.4 Statistical Analysis 
All the samples with an exponential-amplification curve crossing the threshold (Cp) were considered 
positive for T. gondii, samples with no amplification curve for the T. gondii target but amplification 
of the NCIAC were considered negative. As described in Gisbert Algaba et al. (2017), the limit of 
detection of the method is 65.4 parasites per 100 g of tissue. For each round of samples a positive 
control with a known number of parasites (calibrator) was performed to correct for possible 
deviations due to manipulation errors.  
 
A Neighbor-Joining tree was reconstructed from microsatellite data to examine the relationships 
between strains collected from human and porcine isolates originated from Belgium. The tree was 
constructed as described by Ajzenberg et al. (2016). 
 
6.3. Results  
6.3.1 Porcine toxoplasma isolates 
The pilot study yielded a total of 15 seropositive pigs (16.3 %) representing 6 organic farms. The 
actual presence of the parasite in hearts was confirmed by MC-qPCR in 14 pigs representing 5 
organic farms (Farms: A, D, G, L and O). In Farm D and G, T. gondii was found in all the animals 
tested (D:1/ 1 and G:6/6), while in farms A, L and O only some of the tested animals were found 
positive (A: 1/3; L: 4/6; O: 2/3). Finally, 9 strains were successfully isolated by mouse bioassay 
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demonstrating the infectivity and viability of the parasite present in these samples. The results are 
summarized in supp. Table 6.1. 
 








ISP_A1 NA NA Neg 
ISP_A2 NA NA Neg 
ISP_A3 30.40 3.66 Pos 
ISP_D1 29.40 3.99 Pos 
ISP_G1 31.22 3.40 Neg 
ISP_G2 30.49 3.63 Pos 
ISP_G3 32.48 2.99 np 
ISP_G4 29.02 4.11 Pos 
ISP_G5 28.79 4.19 Pos 
ISP_G6 28.51 4.28 Pos 
ISP_L1 28.55 4.27 Pos 
ISP_L2 25.48 5.26 Pos 
ISP_L3 32.58 2.96 Pos 
ISP_L4 31.56 3.29 Neg 
ISP_L5 NA NA Neg 
ISP_O1 28.78 4.19 Pos 
ISP_O2 33.50 2.66 Neg 
p. load: log 10 (number of parasites per 10 g of tissue); NA: negative result; np: not performed; pos: positive 
result; neg: negative result. 
 
6.3.2 Human Toxoplasma isolates 
A seroconversion was confirmed for one or more of the mice inoculated with the positive samples. 
The isolated strains were cryopreserved for further studies.  
 
6.3.3 Molecular epidemiology 
All the human (N=15) and pig isolated strains (N=9) were identified as archetypal type II strains 
(Table 6.2). Additionally, the fingerprinting analysis resulted in the identification of 3 different 
clusters within the pig isolates. Two different clusters were found inside one farm and  the other 
cluster identified represented all the genotyped samples from other farm (n=2). The fourth cluster 
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Fig 
6.1: Neighbor-joining clustering of T. gondii strains based on 15 microsatellite markers. Squares represent 
reference strains for different haplogroups: GT1 (haplogroup I), ME49 (haplogroup II), CTG (haplogroup III), 
TgCatBr01 (haplogroup IV), TgCatBr05 (haplogroup VIII), TgCatBr15 (haplogroup IX), RUB (haplogroup 
v), VAND (haplogroup X), RAY (haplogroup XII), TgH20005 (haplogroup XVI), TgCatBr09 (haplogroup 
VI); the orange points represent the human isolates from this study; the red points represent the porcine 
isolates from this study 
6.4. Discussion and conclusions 
T. gondii infections in humans pose a health threat for the infected patients. The unborn fetus and 
immunocompromised individuals are particularly susceptible to develop the most severe 
consequences of the disease (Dubey, 2010; Robert-Gangneux and Dardé, 2012). 
 
Pork is considered among the most important sources of T. gondii infection in humans in developed 
countries (Batz et al., 2012). The presence of the parasite in the different tissues of the pigs has been 
demonstrated by several studies (EFSA, 2016; Jennes et al., 2017; Verhelst et al., 2015; Gisbert 
Algaba et al., 2017). However little or no information is available on the genetics of the circulating 
T. gondii strains in pigs in the EU. 
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In the present study, we were able to successfully isolate and genotype nine strains originating from 
pigs raised in five organic farms located in Belgium. We also tried to isolate T. gondii strains from 
conventional farms with controlled housing conditions in which seropositive pigs were found, but 
were not successful (data not shown). All the isolated strains were identified as classical type II 
strains. Two different clusters were found on the same farm indicating that the animals were exposed 
to different strains and/or infectious sources. The other cluster identified represented all the 
genotyped samples from one farm indicating a common source of infection for all these animals 
(n=2). Studies performed in other European countries have consistently identified type II as the most 
prevalent in livestock; such as, 17 strains isolated from pigs in the Czech Republic (Slany et al., 
2016) and 100% and 97 % of the isolates from sheep in the Netherlands and France, respectively 
(Halos et al., 2010; Opsteegh et al., 2010). Recently, a study performed in Belgian wildlife showed a 
highly clonal population of T. gondii circulating strains in foxes where 25 strains out of 26 were 
identified as type II strains and only one as a type III strain (De Craeye et al., 2011). 
 
All the human strains isolated in the current study were also identified as type II strains and two 
strains had identical genotyping result suggesting a common source of infection (Table 6.2). These 
findings are in agreement with other studies where different collections of T. gondii isolates were 
genotyped (Dardé et al., 1992; Howe and Sibley, 1995; Ajzenberg et al., 2002). For example, in 
France, 84 % the strains isolated between 1987 and 2001 were identified as type II; the other 
genotypes, type I and type III accounted for 8.14 % and 2.33 %, of the isolates, respectively 
(Ajzenberg et al., 2002).  
 
Overall in the present study, 15 of the hearts originating from pigs raised in organic farms tested 
positive by MC-qPCR, demonstrating the presence of the parasite in animals intended for human 
consumption. These results demonstrate the higher risk that organic farms may pose to the consumer 
regarding T. gondii infections. The highly related population structure of the strains isolated during 
2015 and 2016 in humans and pigs, indicates a potential flow of strains from pigs to humans and/or 
common source of infection (cat oocysts). These findings reinforce the identification of pork as a 
potential risk for the consumers. 
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Table 6.2: Overview of the genotyping results for the isolated strains  
 Host 
species  






























158 169 289 356 207 242 274 336 105 213 310 109 142 174 NA 
Type II 
(14/15) 
TgSsCr_D1 158 169 289 356 207 242 274 336 91 221 310 113 140 174 273 
Type II 
(15/15) 
TgSsCr_O1 158 169 289 356 207 242 274 336 95 215 308 123 140 174 263 
Type II 
(15/15) 





ISP_BLO 158 169 289 356 207 242 274 336 91 213 312 123 147 176 257 
Type II 
(15/15) 
ISP_FOU 158 169 289 356 207 242 274 336 95 213 310 111 140 174 287 
Type II 
(15/15) 
ISP_RAU 158 169 289 356 207 242 274 336 95 215 308 115 140 174 267 
Type II 
(15/15) 
ISP_BOU 158 169 289 356 207 242 274 336 105 223 314 115 140 174 275 
Type II 
(15/15) 





158 169 289 356 207 242 274 336 87 217 308 115 140 174 277 
Type II 
(15/15) 





158 169 289 356 207 242 274 336 87 217 308 115 140 174 277 
Type II 
(15/15) 
ISP_VAN 158 169 289 356 207 242 274 336 83 227 310 109 145 174 289 
Type II 
(15/15) 
ISP_BEN 158 169 289 356 207 242 274 336 91 221 312 111 142 174 259 
Type II 
(15/15) 
ISP_MEN 158 169 289 356 207 242 274 336 99 215 308 109 142 174 275 
Type II 
(15/15) 
ISP_MOU 158 169 289 356 207 242 274 336 85 215 312 111 140 174 275 
Type II 
(15/15) 
ISP_JOS 158 169 289 356 207 242 274 336 97 213 308 119 140 174 261 
Type II 
(15/15) 




: cluster 1; 
b
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Toxoplasma gondii is an ubiquitous apicomplexan parasite with three different infectious stages and 
various routes of transmission. Its ability to infect any warm-blooded animal including humans 
(zoonotic) and its capacity to be transmitted between intermediate hosts bypassing the sexual 
replication in the definitive host (Felidae) have gained it the title of the most successful parasite 
worldwide. Being zoonotic and worldwide prevalent, T. gondii has become a parasite of global 
interest and there is an increasing awareness of its public health and economic importance.  
 
To date, different strategies estimating the burden of disease in the field of public health have 
revealed the high importance of long time neglected diseases such as toxoplasmosis, which ranks 
among the most important. The key feature of these studies is the combination of mortality and 
morbidity into a single and easy to use metric (Devleesschauwer et al., 2014). Recently, a study 
performed in Europe, using the Disability-Adjusted Life Years (DALYs), which is a measure of 
overall disease burden, estimated that more than 180 years are lost due to congenital toxoplasmosis 
only in Belgium during 2013 (Smit et al., 2017). In addition a study performed in the US situates the 
combination T. gondii and pork on the top 2 of pathogen-food combinations in function of Quality-
Adjusted Life Years (QALYs) (Batz et al., 2012) 
 
Despite all these studies demonstrating the importance of T. gondii in human and animal health and 
the recommendations of the competent European food safety authorities to monitor for the presence 
of T. gondii in food, no screening programs are yet implemented in any country. 
 
The general objective of this doctoral thesis was to study the role of pigs and their meat products in 
the transmission of T. gondii to humans. To answer this scientific question, different experimental 
studies were performed: 1) to develop an efficient and sensitive ISO validated molecular method for 
the detection of T. gondii in meat (Chapter IV); 2) to study the infection kinetics in experimentally 
infected pigs (Chapter V); 3) to detect, isolate and characterise T. gondii strains circulating in pigs 
by molecular epidemiology and to compare the genotypes with human genotypes circulating in 
Belgium (Chapter VI). 
7.1 Optimization of the parasite’s detection in the host tissues  
In the present dissertation, we successfully optimized the MC-qPCR method (Chapter IV) making it 
more sensitive and reproducible than the previously developed methods, including the mouse 
bioassay (reference method). The detection of T. gondii infection can be performed either by 
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serological methods or by direct detection of the parasite. However, only direct methods will 
demonstrate the actual presence of the parasite in the tissues, which is needed to properly evaluate 
the risk of meat in human infections. To date direct detection of the parasites in the tissues is still 
challenging due to a low tissue cyst density which requires at least 100g of tissue to have reliable 
results. Consequently, commercially available DNA extraction kits have been proven to be 
insufficiently sensitive due to the limited amount of sample that can be tested. A major improvement 
of the sensitivity was achieved with a Magnetic Capture based DNA extraction, where the parasitic 
DNA can be selectively concentrated from a large volume of sample and the parasite burden 
subsequently quantified by qPCR (Opsteegh et al., 2010).   
 
In the present study, we succeeded to develop a UV dependent release of the target DNA from the 
beads rendering the method more efficient and avoiding thermic treatment of the samples to elute the 
parasitic DNA from the beads. The thermic treatment used in the originally developed MC-qPCR 
may result in iron leaking from the beads with subsequent inhibition in the qPCR. This elegant 
approach allowed us to overcome the sensitivity and variability issues shown in previous studies 
where MC-qPCR was still less sensitive than mouse bioassay. Moreover, we subjected the new 
method to an ISO 17025 validation to objectively confirm its robustness and reliability for routine 
use in a diagnostic lab. We achieved this by adding the co-capture of cellular r18S which helps to 
track the extraction step and serves as a non-competitive PCR inhibition control. The robustness of 
the modified MC-qPCR method was clearly reflected in the results of the validation process with a 
coefficient of variation (CV) lower than 5%, the higher sensitivity of the MC-qPCR compared to the 
mouse bioassay (Sensivity MC-qPCR: 94.12% Sensitivity mouse bioassay: 86.49%), the broad range 
of matrices that can be analysed and a lower limit of detection than the previous methods (65.4 
Tachyzoites or 1 cyst per 100 g of tissue). 
Overall, our results demonstrate the potential of the modified MC-qPCR as a reliable alternative with 
regards to the mouse bioassay for archetypal T. gondii strains (Type I, Type II and Type III). This 
method can be used in monitoring programs as it overcomes the main drawbacks of the mouse 
bioassay: ethically questionable, expensive and time consuming. While the turnaround time (TAT) of 
mouse bioassay is at least 48 days, the MC-qPCR can give results within only 2 days after reception 
of the samples keeping in line with the short shelf-life of meat and most of the meat products. 
Additionally, a higher number of samples can be simultaneously processed which also represents an 
advantage for monitoring program. 
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Whereas the MC-qPCR has a shorter TAT (2 days) and is cheaper than the bioassay, a major 
disadvantage of this technique is the lack of information provided on the viability of the parasites as 
further discussed in point 7.4.2. Importantly, the costs of this technique are still too high for routine 
testing; they are estimated to be 100€ per sample, including the costs of personnel. 
 
Besides these two disadvantages, this method can be potentially used to consider T. gondii-free the 
tested meat at high certainty level, which represents a major advantage for sensitive target population 
groups, such as immunocompromised patients or pregnant women who would assumedly agree to 
buy more expensive but safer food products. Freezing meat products in order to make them safe is 
another option, but presents some issues such as keeping the cold chain and the lower organoleptic 
quality of frozen products. 
 
7.2 Study the infection kinetics of experimentally infected pigs  
We used the newly upgraded and ISO 17025 validated MC-qPCR (Chapter IV) to demonstrate a 
high parasite burden in different muscular tissues of experimentally infected animals confirming the 
risk of pork as a source of infection for humans when consumed raw or undercooked (Chapter V). 
The MC-qPCR allows the study of the quantitative distribution of the parasite through the carcasses 
in different animal species and the assessment of the risk of infection for the consumer of the 
different animal tissues. In the present study, the lungs and heart were identified as the most 
parasitized tissues independently of the infectious stqge and strain used during the acute and chronic 
phase of infection, respectively. These two tissues are of pivotal importance to demonstrate an actual 
presence or absence of the parasite in the animals. To date, in pigs, the parasite burden has been only 
studied following experimental infections with oocysts or tissue cysts but a comparison of the 
parasite burden in the tissues after an infection with either one of the two infectious stages had not 
yet been done. Here, we demonstrate a consistently higher parasitic load in all the tested tissues 
except for the diaphragm in animals infected with oocysts in comparison to infection with tissue 
cysts. As a result of the experimental infections, diaphragm has been shown to carry one of the 
lowest parasite burden from all the tested tissues making it an inappropriate tissue to demonstrate the 
presence of the parasite in pigs. 
 
An effect of the genetic profile of the T. gondii inoculum on the parasitic load in some tissues was 
observed in previous studies. Indeed, infection with a hybrid Type I/II strain (T. gondii ISP-Gangji) 
resulted in a more pronounced clearance of the parasite in some tissues when compared to a classical 
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type II strain (Verhelst et al., 2011; Jennes et al., 2017). Remarkably, infection with the same strains 
showed a small or negligible effect on the parasite burden in the pig’s tissues in our study. The 
existence of many different strains of T gondii, the large variation in the individual host response to a 
T. gondii infection and the different infection protocols make interpretation and comparison of 
results difficult.  
 
In conclusion, these findings confirm the importance of pork as a source of infection for humans. All 
the tissues tested (M. gastrocnemius, M. longissimus dorsi, diaphragm, intercostal muscles, M. psoas 
major, heart and brain) showed the presence of the parasite.  Heart and brain were the most 
parasitized tissues during the chronic phase of infection (predilection tissues for the detection of the 
parasite during the chronic phase) whereas heart and lungs were most parasitized during the acute 
phase of infection (predilection tissues during the acute phase of infection). Additionally, pigs 
infected with oocysts may pose a higher risk for the consumer due to the higher parasite burden in 
the tissues following infection, as found in this study.  
7.3 Molecular epidemiology of T. gondii in Belgium  
We applied succesfully a combined strategy (serological and molecular) to demonstrate the actual 
presence of infectious T. gondii in the tissues of naturally infected pigs intended for human 
consumption and the potential flow of strains from pigs to humans (Chapter VI). Furthermore, we 
aimed to identify the circulating strains in both humans and pigs and perform a molecular 
epidemiological study comparing the isolated strains. Besides the wide spectrum of intermediate host 
and the various routes of transmission, T. gondii shows a very structured genetic population in 
Europe and North America with three main lineages also referred to as archetypal strains (Types I, II 
and III) with the type II strains as the most predominant in humans and livestock species. However, 
no data were available on the genetic profile of the strains circulating in the Belgian human 
population or in any of the main livestock species.   
 
Based on the results obtained from the experimentally infected animals (Chapter V) and the 
preliminary results of a T. gondii seroprevalence study in Belgium in which the prevalence in organic 
farms was consistently higher than in intensive production systems (Jennes et al., unpublished 
results), we decided to collect samples from a slaughterhouse specialized in organic pigs located in 
Malmedy (Wallonia, Belgium). In order to reduce the costs and the efficiency of the study, first the 
pigs were serologically screened for Toxoplasma antibodies, then confirmation of the presence of the 
parasite in the heart of seropositive pigs was done by MC-qPCR, whereafter the parasite was isolated 
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in mice (bioassay). The human strains were isolated by the National Reference Center (NRC) for 
Congenital Infections in Belgium during 2015 and 2016. 
 
In the present study, 14 of 94 hearts originating from pigs raised in organic farms tested positive by 
MC-qPCR of which nine were isolated in mice, demonstrating the presence of viable parasites in 
animals intended for human consumption. When genotyped and compared to the human strains, a 
highly related structured population was demonstrated with all the isolated strains for both species 
classified as Type II strains. Indeed, the strains isolated from humans and pigs show a very similar 
genetic profile suggesting a probable flow of strains from pigs to humans or a common source of 
infection (cat oocysts). 
 
Remarkably, this combined approach was also used to try to isolate strains from industrial pig farms 
where the controlled housing conditions makes contact of the animals with the parasite more 
challenging. Although positive serological results can be found in these industrial farms, we were not 
able to isolate any strains (unpublished data), probably due to the lower prevalence of infected 
animals in those farms, a lower parasite burden as it is thought that animals are mostly infected by 
ingestion of chronically infected rodents (lower parasite burden after infection with tissue cysts, 
Chapter V) and the larger size of the herds which makes the sampling more challenging. 
 
These findings, point out the farm management and especially the housing conditions as most 
important factors allowing T. gondii infections in pigs. Currently, there is a trend moving towards 
more animal-friendly production systems (organic farms) and farms where the pigs have outdoors 
access allowing more exposure to the parasite. In addition, and as a result of globalisation, nowadays 
pork is imported from countries where the hygienic and management farm measures can be less 
stringent than in the EU and where the animals can be exposed to atypical strains that can be more 
virulent to the pork consumers than the current European strains.  
 
To prevent this, different measures can be adopted such as the implementation of the MC-qPCR to 
identify parasites in tissues from pigs raised outdoors; avoiding the use of contaminated tissues for 
meat products consumed fresh and the obligation of freezing T. gondii seropositive pig carcasses 
before consumption. Additionally, the obligation to freeze pork products originating from outside the 
EU to avoid the incursion of atypical strains inside our borders can be considered. 
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7.4 Unresolved questions  
Today, more than hundred years after T. gondii was first described in 1908 and despite the intense 
research resulting in the elucidation of its complete life cycle, the different infectious routes and 
stages, the determination of its wide intermediate host spectrum and its phenotypic and genotypic 




Fig. 7.1 Overview of the main unresolved questions 
 
7.4.1 The cat, the human and the so-called cat disease 
Since the elucidation of the final life cycle of T. gondii pointing felids as the definitive hosts, T. 
gondii infection in humans has been associated with cats and their shedding of millions of infectious 
oocysts in the environment (Torrey and Yolken, 2013). Actually, some of the few known registered 
T. gondii outbreaks have been epidemiologically associated with infection with oocysts: i) a group of 
three women in Victoria, Canada whose infection in 1994-1995 was attributed to oocysts 
contaminating the drinking water of the city, ii) a group of 39 individuals who likely got infected by 
ingestion of aerosolized oocysts in Georgia, Atlanta in 1977. However, the origin of these infection 
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Recently, the identification and cloning of a sporozoite stage-specific recombinant antigen (TgERP) 
has enabled to determine the oocyst source of infection in function of the presence/absence of Ab 
against this stage-specific antigen (Hill et al., 2011). However, as TgERP is only expressed during 
the early phase of infection by sporozoites, the Ab titers will decrease in function of time rendering 
the differentiation of the source of infection in old or chronic infections difficult. In the study of Hill 
et al. (2011), the presence of Ab against TgERP was detected in 63.2 % individuals in the acute stage 
of infection (103/163) and in 17.6 % individuals in the chronic stage of infection (31/176). Brazilian 
scientists identified and cloned a different sporozoite stage-specific recombinant antigen (CCp5A), 
which is also able to discriminate between an infection with oocysts or tissue cysts but poses the 
same issues regarding chronic infections (Santana et al., 2015).  
 
The development of a sporozoite-specific detection method is a major breakthrough in the 
understanding of the epidemiology of T. gondii infections in humans and animals. Once the main 
source of infection is established, more targeted strategies can be applied to minimize the number of 
human and animal infections. However, it appears that the results from those studies seem to be 
difficult to reproduce). The development of a commercially available and standardized sporozoite 
detecting serological test may overcome this problem.  
 
7.4.1 Tissue cysts, a needle in a haystack 
Since the transmission of T. gondii by meat consumption was first suggested (Weinman and 
Chandler, 1954) and confirmed to also occur in humans (Desmonts et al., 1965), carnivorism has 
been considered as one of the main routes of infections of T. gondii for humans in developed 
countries (Cook et al., 2000; Scallan et al., 2011; Batz et al., 2012; Opsteegh et al., 2016). 
 
Tissue cysts are the result of the extra-intestinal phase of the parasite in both the definitive and the 
intermediate hosts and they can remain lifelong in the tissues of the host. Resistant to any antibiotic, 
the concentration and size of the cysts in the tissues is extremely variable depending of the dose of 
infection, the immune system of the infected host species and even of individuals within a species. 
Sometimes the homogeneity and density of tissue cysts in the tissues is so low that the direct 
detection of T. gondii in tissues represents a challenge. To overcome this sensitivity problem very 
sensitive techniques have been developed such as, the MC-qPCR described in Chapter IV. 
However, the high cost of this technique makes it difficult to implement in routine diagnostic 
practices. Therefore, the development of a very sensitive technique with a reasonable prize is one of 
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the challenges for the near future. 
 
7.4.2 The old tale of sensitivity and viability 
Even though very sensitive, the Mc-qPCR described in Chapter IV is only able to demonstrate the 
presence of the parasitic DNA in the tissues of the host but does not give any information on the 
viability of the parasites and thus their ability to infect other hosts. In this study, the correlation 
between the mouse-bioassay and the MC-qPCR was compared using the Cohen’s kappa index 
resulting in a substantial agreement between both methods (Cohen’s Kappa: 0.74). However, the 
different results observed with these two methods can be explained either by the higher sensitivity of 
the MC-qPCR compared to the mouse bioassay or by the fact that some of the parasites found with 
MC-qPCR were no longer viable and thus unable to initiate an infection in the inoculated mice.  
 
To the best of our knowledge, this is one of the unresolved questions that needs to be addressed in 
the near future, eg by the development of a sensitive molecular detection RNA-based method able to 
address viability of the parasites. However, the new method will need to have a sensitivity 
comparable to MC-qPCR or at least equivalent to the mouse bioassay. Such a test would greatly 
reduce the number of experimental animals used in the frame of toxoplasmosis diagnosis.  
7.4.3 Livestock, Who is Who? 
Toxoplasma gondii infection in humans has been consistently associated with the consumption of 
raw or undercooked meat of the main livestock species (Dubey, 2010). However, which species 
account for the majority of the human infections varies between studies and countries. For example, 
41% of the cases of foodborne human toxoplasmosis in the United States are estimated to be caused 
by the consumption of pork, which can thus be considered as a main source of infection for humans 
(Batz et al., 2012).  However, in the Netherlands, it was estimated that only 11 % of meat borne T. 
gondii infections in humans are due to pork, while the majority (68%) of the meat borne infections 
could actually be attributed to beef consumption (Opsteegh et al., 2011). Remarkably, although cattle 
are more exposed to T. gondii oocysts than pigs because of their more intense contact with the 
environment, tissue cysts seem not to persist long in most of the cattle tissues, suggesting a clearance 
of the parasite in infected animals (Opsteegh et al., 2016). In pigs, T. gondii is thought to remain 
lifelong in the tissues of the animals (Dubey, 2010).  
 
As explained above, the parasite burden in different tissues differs from one livestock species to 
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another. In pigs and sheep, the heart has been described as the predilection tissue to find the parasite 
and the presence of the parasite has been described in many tissues of experimentally and naturally 
infected animals. On the other hand, a recent study suggests the liver to be a better tissue to 
demonstrate the presence of T. gondii in cattle (Opsteegh et al., 2016).  
7.4.4  New diagnostic approaches, the future is now 
Science is continuously evolving and with it the approach towards diagnosis and treatment of 
infectious diseases. The diagnosis of toxoplasmosis, including the detection of antibodies against T. 
gondii and the demonstration of the presence of T. gondii in the tissues, have improved considerably 
during the last decades as shown in previous sections of this chapter (Chapter VII). However, there 
is still room for improvement. Here we summarize a few new developments in this field that may 
impact our understanding of T. gondii in the near future.  
Detection of T. gondii oocysts in water  
As already explained in Chapters I and II, felids shed large numbers of oocysts following infection 
with T. gondii. These resistant stages play a pivotal role in spreading the disease to a wide range of 
intermediate hosts, including humans. Although the number of feral cats in urban areas has decreased 
significantly in developed countries during the last decades, as a result of communal spay/neuter 
programmes, keeping domestic cats is becoming increasingly popular as cats easily fit in our busy 
modern lives (Walden, 2015). A study in California has estimated that among owned cats, 44% 
defecates outside at least 75% of the time, and 8% uses both a litter box and defecates outdoors 
between 25% and 75% of the time. Furthermore, it was also estimated that 87% of the cat owners 
dispose the litter boxes in the normal garbage, while 4% discard the content near their property and 
9% flush the litter in the toilet (Torrey and Yolken, 2013). Many of these oocysts will potentially end 
up in the surface water and the sea as confirmed with the findings of accumulation of T. gondii 
oocysts in bivalves and T. gondii infections in sea mammals (Palos Ladeiro M., 2014; van de Velde 
et al., 2016). 
 
Up to day, sensitive and efficient detection of T. gondii oocysts in water is still challenging due to the 
low density of oocysts and the lack of a commercially available immunomagnetic separation (IMS) 
technique. However, bivalves with their ability to accumulate oocysts and their high capacity to filter 
big volumes of water (up to 100 litres a day for oysters) can become a natural concentrator of oocysts 
present in water samples. The final detection of the oocysts could then be performed by testing these 
bivalves by qPCR. This alternative approach can become a good alternative to detect T. gondii 
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oocysts in large volumes of water. 
Detection of T. gondii in vegetables and crops 
Crops and vegetables can be contaminated with oocysts in different ways, during primary production 
(direct shedding of oocysts, contaminated irrigation water, etc.), during transport and market 
processing or directly by the food handlers (Caradonna et al., 2017). As it happens with the oocysts 
in water, a low density of oocysts and the lack of a specific concentration method makes the direct 
detection of oocysts in fruits, vegetables and crops very challenging. However, with a similar 
approach to the one described in Chapter IV (MC-qPCR), a specific concentration of T. gondii DNA 
is possible once the sample is lysed. For this, disrupting the cell wall and the oocysts walls pose the 
main challenge. This obstacle could be eventually overcome with the use of specific enzymes to 
disrupt the cell wall and different cycles of freezing and thawing in liquid nitrogen to lyse the 
extremely resistant oocyst walls. 
Luminex, date and source of the infection 
Luminex is a new technique which uses microspheres that can be coated with different types of 
biomolecules: 
 Specific antigens in order to detect antibodies against concrete targets 
 Specific antibodies in order to detect concrete antigens 
 Specific DNA sequences in order to capture a target DNA sequence 
 
This technique can be used to estimate more accurately the date and source of infection. During the 
early phase of infection different antigens are expressed by sporozoites as already mentioned in point 
7.4.1, and also some antigens common in bradyzoites and sporozoites are chronologically expressed 
by T. gondii enabling the estimation of the date of infection. First, the surface antigens (SAG) make 
contact with the host cell plasma membrane and once attached MIC proteins are excreted. 
Subsequently rhoptry neck proteins (ROP) and apical membrane antigen 1 (AMA1) and dense 
granule proteins (GRA) account for the final steps of the penetration and the formation of the 
parasitophorous vacuole (PV) (De Craeye, 2012).  An overview of the process and the proteins 
implied during the host cell invasion is shown in Figure 7.2.  
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Fig.7.2 Overview of the cell penetration process by T. gondii, adapted from De Craeye, 2012. 
 
Hence, the use of beads coated with these specific antigens and the antigens described in point 7.4.1, 
will help to date the T. gondii infection and characterize the infectious stage. The combination of this 
technique with an exhaustive epidemiological analysis might result in the identification of the 
concrete source of infection. 
Proteomics and the ion trap spectrometry 
T. gondii is considered to be able to express at least 6500 different proteins and it is estimated that 
only 30% of the T. gondii proteome has been detected (Xia, et al., 2008; Fritz et al., 2012). However, 
the majority of studies has been limited to tachyzoites and not much information exists on the 
proteomics of the other two infectious stages (bradyzoites and sporozoites). The proteomic 
description of these other stages may enable a better understanding of the T. gondii biology. 
 
Nowadays, various analytical disciplines contribute to the elucidation of the proteomic potential of T. 
gondii, but mass spectrometry has become the method of choice for analysis of complex protein 
samples (Trajkovic, 2014).  
 
Although polar, nonvolatile and thermally unstable, peptides eluted from the liquid chromatography 
system can be analyzed with an appropriate sample introduction such as electrospray ionization 
(ESI) as it transfers peptides to the gas phase without degradation (Trajkovic, 2014). 
 
This technique can allow the identification of T. gondii proteins involved in the penetration of the 
host cells, the transformation into bradyzoites, the tissue cyst formation, etc., with the additional 
value of giving more information such as post-translational modifications (PTM) (Trajkovic, 2014). 
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7.4.5 Vaccines, the work and the interest 
Since the discovery of the consequences for public health deriving from T. gondii infections, the 
development of a vaccine has been the foundation stone of several research studies. During the last 
decades several vaccines have been developed using different approaches: 
 The use of recombinant DNA technology to produce specific recombinant antigens in 
bacteria 
 The lysis of the parasites making a pool of the expressed parasite antigens to induce 
immunity 
 The use of attenuated mutant strains which will give immunity to the infected hosts with no 
associated clinical signs 
 The use of naked DNA vaccines consisting of plasmid DNA into which the relevant gene or 
genes of the parasitic agent has been inserted   
 
When developing a vaccine three main aims have to be considered: i) Limit the acute parasitemia 
and protect against congenital toxoplasmosis; ii) Reduce the number of tissue cysts found in the 
different tissues of the intermediate and definitive hosts; iii) Reduce to a minimum or even prevent 
the shedding of oocysts by cats. 
 
Up to date, only one vaccine is commercially available (Toxovax®) in some countries for veterinary 
use. It consists of attenuated live parasites. Toxovax is used to limit the incidence of abortion in 
sheep and it has been demonstrated to be effective for at least 18 months. However, the vaccination 
needs to be repeated every two years and it does not eliminate the parasite (Kur et al., 2009). 
Unfortunately, Toxovax cannot be used in humans because it is an attenuated live vaccine and can 
regain virulence resulting in iatrogenic infections (Kur et al., 2009). 
 
Once an effective and safe vaccine preventing congenital transmission and the oocyst shedding by 
cats is developed, the major objective will be to convince and commercialize this vaccine. 
Fortunately, currently there is an increasing awareness of the Public Health impact of human and 
animal toxoplasmosis and several studies are performed showing the economic loss associated with 
this worldwide prevalent parasite. Therefore, the implementation of vaccination and educational 
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Toxoplasma gondii is a zoonotic parasite of global interest. Nowadays, there is an increasing 
awareness worldwide of its public health and economic importance. In humans, the majority of 
infections are asymptomatic or, on rare occasions cause mild flu-like symptoms. However, infection 
may produce congenital disease if a primary infection occurs in pregnant women, potentially leading 
to abortion, fetal abnormalities, perinatal death and reduced quality of life in surviving children. 
Additionally, toxoplasmosis can result in severe disease in immunocompromised people and serious 
eye disease in otherwise healthy individuals. In livestock, infection with T. gondii may be associated 
with reproductive disorders, reduced weight gain and weak progeny, with consequently, important 
economic losses for producers. Among the different routes of transmission to humans the 
consumption of undercooked or raw meat is very important. Pork is considered to be among the main 
sources of human infection. This thesis aims at generating knowledge on the role of pigs in the 
transmission of the parasite by developing an improved detection method of T. gondii in pig tissues, 
studying the distribution and survival of the parasite in experimentally infected pigs, and by isolating 
and genotyping T. gondii strains from Belgian pigs. 
 
The literature study (Part I) provides a wide overview of the currently published research regarding 
the most important features of T. gondii considered as one of the most successful parasites 
worldwide. The first chapter (Chapter I) describes the morphology and biology of the different 
infectious stages as well as T. gondii’s complex life cycle with intermediate and definitive hosts. In 
addition, a short overview of the molecular epidemiology is given. 
 
Chapter II describes the main routes of transmission between the intermediate and definitive hosts 
or between intermediate hosts along with the significant impact of the parasite on humans and 
livestock health and its economic importance for Public Health. 
 
Finally, in Chapter III the different approaches and techniques for diagnosis of T. gondii are 
described, emphasizing on their advantages and limitations in order to demonstrate recent or old 
infections and presence or absence of the parasite in the tissues. 
 
The experimental part (Part II) starts by situating the main problems studied in the present 
dissertation and as such by giving the aims of this PhD study. It continues with a detailed description 
of the different experimental studies performed to answer these objectives.  
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The general objective of this study was to study the role of pork and other meat products products as 
a source of T. gondii infection in humans. More in detail, the specific objectives were to develop an 
efficient and sensitive ISO validated molecular method for the detection of T. gondii in various 
tissues, to study the infection kinetics in experimentally and naturally infected pigs to better assess 
the role of pork as a source of infection and finally to detect, isolate and study the circulating T. 
gondii strains in Belgian pigs. 
 
In Chapter IV we present an efficient and ISO 17025 validated MC-qPCR method for the detection 
of archetypal T. gondii strains in meat, published in the International Journal for Parasitology 
(Gisbert Algaba, et al., 2017). The method combines the hybridization of specific, biotinylated 
probes with the capture of those probes with streptavidin coated paramagnetic beads and the release 
of the target DNA from the beads by exposure to UV light. That way, T. gondii DNA can be 
selectively concentrated from a large volume of sample increasing significantly the sensitivity of the 
technique. The results showed a more sensitive (99% LOD of 65.4 tachyzoites per 100 g of meat and 
sensitivity: 94.12 %), economic and reliable method than the reference bioassay method. Actually, 
they demonstrate the potential of this method as full alternative for the mouse bioassay for screening 
of various tissues and meat, with the additional advantage of being quantitative.  
 
In Chapter V we describe the effect of different T. gondii strains and infectious stages on the 
parasitic load in pig carcasses (Gisbert Algaba et al., accepted). Here we used the MC-qPCR to 
quantitatively address the presence of the parasite (parasitic load) during the acute (0-28 days post 
infection) and chronic (3-4 months post infection) phases of infection along with a comparison of the 
parasite burden in function of the different infectious stages and strains used in experimentally 
infected pigs. The highest burden of infection was found in heart and lungs during the acute phase of 
infection while heart and brain were identified as the most parasitized tissues during the chronic 
phase of infection, independently of the infectious form and the strain used. Remarkably, a higher 
parasite burden was measured in different tissues following infection with oocysts when compared 
with a tissue cyst infection during the chronic phase of infection and additionally no significantly 
different parasite burden resulted from infection with two different strains.  
 
Chapter VI describes the molecular epidemiology of T. gondii isolates originating from Belgian 
pigs and humans (Gisbert Algaba et al., submitted). In this study we focus on the detection and 
isolation of different T. gondii strains in pigs and the comparison of these strains with those isolated 
in the frame of the National Reference Centre for Congenital Infections in Belgium. Overall, in the 
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present study, 14/92 hearts originating from pigs raised in organic farms tested positive by MC-
qPCR, demonstrating the presence of the parasite in animals intended for human consumption. 
Moreover, the highly related population structure of the strains isolated during 2015 and 2016 in 
humans and pigs (24/24 type II strains) indicates a potential flow of strains from pigs to humans. 
These findings reinforce the identification of pork as a potential risk for the consumers and 
demonstrate the higher risk that pigs from organic farms pose to the consumer regarding T. gondii 
infections 
 
In Chapter VII, a general discussion is provided stressing the contribution of the presented studies 
to a better understanding and awareness of human and animal toxoplasmosis and more specifically, 
the identification of pork and its pivotal role as a source of infection for humans using the MC-
qPCR, a very sensitive molecular method able to detect only one tissue cyst per 100 g of meat. 
However, this method is not able to differentiate between viable and non-viable parasites which is 
discussed along with the main unresolved questions and new potential approaches for the detection 
of T. gondii in this chapter.   
 
In conclusion, the present dissertation provides a new assay for the detection of T. gondii that can 
replace the mouse bioassay. The test allowed to determine the parasite distribution in the host tissues 
during the acute and chronic phases of infection as well as the effect of infection with different 
strains and infectious stages of the parasite on the parasite burden. Furthermore, a molecular 
epidemiology study showed a highly related structured population with all the isolates classified as 
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Toxoplasma gondii is een zoönotische parasiet met een wereldwijde impact. De laatste jaren is het 
bewustzijn omtrent het economisch en volksgezondheidsbelang van deze parasiet danig toegenomen. 
Humane infecties verlopen meestal asymptomatisch of gaan in zeldzame gevallen gepaard met milde 
griepachtige symptomen. Congenitale aandoeningen kunnen echter optreden wanneer de primo-
infectie plaatsvindt tijdens de zwangerschap. Dit kan aanleiding geven tot abortus, foetale 
abnormaliteiten, perinatale sterfte en een verminderde levenskwaliteit van de overlevende kinderen. 
Verder kunnen ernstige symptomen waargenomen worden bij immunodeficiënte patiënten, als ook 
oogaandoeningen bij gezonde patiënten. Infecties met T. gondii bij nutsdieren kunnen gepaard gaan 
met reproductiestoornissen, verminderde gewichtstoename en zwakkere nakomelingen. Dit leidt tot 
significante economische verliezen voor de producenten.  
Een van de belangrijke transmissieroutes naar de mens is de consumptie van onvoldoende verhitte of 
rauw vlees. Varkensvlees wordt aanschouwd als een van de hoofdbronnen voor humane infectie. 
Deze thesis heeft als doel meer kennis te verwerven omtrent de rol van varkens bij de transmissie 
van de parasiet. Om dit te realiseren werd een verbeterde detectiemethode voor T. gondii in 
varkensweefsels ontwikkeld, werd de verspreidings- en overlevingscapaciteiten van de parasiet 
onderzocht in experimenteel geïnfecteerde varkens en werden T. gondii stammen geïsoleerd uit 
Belgische varkens en vervolgens gegenotypeerd. 
 
De literatuurstudie (Deel 1) schetst een ruim overzicht van het reeds gepubliceerd onderzoek omtrent 
de voornaamste kenmerken van T. gondii die deze parasiet tot één van de meest succesvolle 
parasieten ter wereld maakt. Het eerste hoofdstuk (Hoofstuk I) beschrijft de morfologie en biologie 
van de verschillende infectieuze vormen van T. gondii, als ook de complexe levenscyclus met tussen- 
en eindgastheren. Hierop volgt een kort overzicht van de moleculaire epidemiologie. 
 
Hoofdstuk II beschrijft de voornaamste transmissieroutes tussen enerzijds tussen- en eindgastheren 
en anderzijds tussengastheren onderling. Verder wordt de significante impact van de parasiet op de 
gezondheid van mens en dier beschreven en de economische belangen geassocieerd met de 
volksgezondheid. 
 
Tot slot wordt in Hoofdstuk III de verschillende aanpakken en technieken voor de diagnose van T. 
gondii beschreven, met aandacht voor de voordelen en beperkingen bij het aantonen van recente of 
oude infecties, en de aan- of afwezigheid van de parasiet in de weefsels. 
 
Het experimenteel gedeelte (Deel II) van deze thesis begint met een situering van de 
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hoofdproblemen behandeld in deze thesis en de doelstellingen van dit doctoraatsonderzoek. Verder 
worden de verschillende experimentele studies die een antwoord bieden aan deze doelstellingen in 
detail beschreven.  
 
De algemene doelstelling van deze thesis is de studie naar de rol van varkens en 
varkensvleesproducten in de transmissie van T. gondii naar de mens. De specifieke doelstellingen 
waren de ontwikkeling van een efficiënte en gevoelige ISO-gevalideerde moleculaire methode voor 
de detectie van T. gondii in verschillende weefsels, de studie van de infectiekinetieken in 
experimenteel en natuurlijk besmette varkens zodat de rol van varkensvlees als infectiebron beter 
ingeschat kan worden en tot slot de detectie, isolatie en typering van de circulerende stammen in de 
varkenspopulatie. 
 
In Hoofdstuk IV wordt een efficiënte en ISO 17025-gevalideerde MC-qPCR methode voorgesteld 
voor de detectie van achetypische T. gondii stammen in vlees, deze methode werd gepubliceerd in de 
International Journal for Parasitology (Gisbert Algaba, et al.,2017). Deze methode combineert de 
hybridisatie van specifieke, gebiotinyleerde proben met het vangen van die proben met streptavidin-
coated paramagnetische beads. Vervolgens wordt het target-DNA losgekoppeld van de beads door 
blootstelling aan UV-licht. Op deze manier kan T. gondii-DNA op selectieve wijze worden 
geconcentreerd in een groot staalvolume, waardoor de gevoeligheid van de techniek significant 
toeneemt. De resultaten toonden aan dat de methode gevoeliger (99% LOD van 65.4 tachyzoïten per 
100 g vlees en sensitiviteit: 94.12 %), economischer en betrouwbaarder is ten opzichte van de 
referentiemethode, namelijk de bio-assay. Deze resultaten demonstreren het potentieel van deze 
methode als alternatief voor de bio-assay op basis van proefmuizen voor de screening van 
verschillende weefsels en vlees. Daarenboven bezit de MC-qPCR methode een extra voordeel, 
namelijk de mogelijkheid tot kwantificatie.  
 
Hoofdstuk V beschrijft het effect van verschillende T. gondii stammen en infectieuze vormen op de 
parasitaire belading van varkenskarkassen (Gisbert Algaba et al., aanvaard). In deze studie wordt de 
MC-qPCR gebruikt voor de kwantificatie van de parasiet (parasitic load) tijdens de acute (0-28 
dagen na infectie) en chronische (3-4 maand na infectie) fase van de infectie. Tevens werd de 
parasitaire belading vergeleken in functie van de verschillende infectieuze vormen en stammen 
gebruikt tijdens de experimentele infectie van de varkens. De hoogste parasitaire belading werd 
teruggevonden in het hart- en longweefsel tijdens de acute fase van de infectie. Terwijl tijdens de 
chronische fase de hoogste belading werd teruggevonden in hart- en hersenweefsel. De gebruikte 
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infectieuze vorm en stam hadden bij beide waarnemingen geen invloed. 
Er werd een opmerkelijk hogere parasitaire belading gemeten in de verschillende weefsels tijdens de 
chronische fase na infectie met oöcysten in vergelijking met weefselcysten. Geen significante 
verschillen in parasitaire belading werden waargenomen door het gebruik van de twee verschillende 
T. gondii stammen. 
 
Hoofdstuk VI beschrijft de moleculaire epidemiologie van T. gondii isolaten afkomstig van 
Belgische patiënten en varkens (Gisbert Algaba et al., ingediend). In deze studie wordt gefocust op 
de detectie en isolatie van de verschillende T. gondii stammen in varkens en de vergelijking van deze 
stammen met deze geïsoleerd in het kader van het Nationaal Referentie Centrum voor Toxoplasmose 
in België. In de huidige studie testten 14 van de 92 harten afkomstig van varkens, opgekweekt op 
bio-boerderijen, positief aan de hand van de MC-qPCR. Dit toont de aanwezigheid aan van de 
parasiet in dieren bestemd voor humane consumptie. De sterk gerelateerde populatiestructuur van de 
stammen geïsoleerd gedurende 2015 en 2016 uit mensen en varkens (24/24 type II strains) geeft de 
mogelijkse stroom van stammen weer vanuit de varkens naar de mens. Deze bevindingen versterken 
de identificatie van het varken als potentieel risico voor de consument en illustreert het hoger risico 
dat varkens van bio-boerderijen vormen voor de consument met betrekking tot T. gondii infectie. 
 
Hoofdstuk VII omvat de algemene discussie waarin de bijdrage van de gepresenteerde studies voor 
een beter inzicht en bewustzijn van de humane en veterinaire toxoplasmosis wordt benadrukt. In het 
bijzonder wordt de identificatie van het varken en zijn sleutelrol als humane infectiebron besproken 
gebruikmakend van de MC-qPCR, een heel gevoelige moleculaire methode (sensitiviteit: 94.12%) in 
staat om één weefselcyste per 100 gram vlees te detecteren. Deze methode is echter niet in staat te 
differentiëren tussen levende en dode parasieten. Andere belangrijke vragen en nieuwe potentiële 
aanpakken voor de detectie van T. gondii worden in dit hoofdstuk beschreven.  
 
Dit doctoraatsonderzoek stelt een nieuwe assay voor die de detectie van T. gondii aan de hand van de 
bio-assay kan vervangen. De assay maakt de het mogelijk om de verspreiding van de parasiet over de 
weefsels van de gastheer vast te stellen zowel tijdens de acute, als de chronische fase van de infectie. 
Bovendien is het mogelijk het effect van verschillende stammen en infectieuze vormen van de 
parasiet op de parasitaire belading van de weefsels te bestuderen. Verder toonde de moleculaire 
epidemiologische studie een sterk gerelateerde populatiestructuur aan. Waarbij alle humane en 
varkensisolaten werden geclassificeerd als type II stammen. 
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